| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | RASGRP4 NCALD RYR2 RYR3 C2CD5 ITPR1 ITPR3 FAT1 HPCAL1 PCDH11X PLCD1 PLCG1 PITPNM2 CACNA1B FAT4 FAT3 PCDH11Y PCDHA7 CUBN PITPNM1 CELSR2 HMCN1 DCHS1 MACF1 EDEM1 PCDH7 CRB2 | 2.76e-07 | 749 | 236 | 27 | GO:0005509 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.11e-05 | 18 | 236 | 4 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 1.98e-04 | 25 | 236 | 4 | GO:0034237 | |
| GeneOntologyMolecularFunction | chitobiosyldiphosphodolichol beta-mannosyltransferase activity | 4.14e-04 | 3 | 236 | 2 | GO:0004578 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 4.14e-04 | 3 | 236 | 2 | GO:0005220 | |
| GeneOntologyMolecularFunction | beta-1,4-mannosyltransferase activity | 4.14e-04 | 3 | 236 | 2 | GO:0019187 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 4.66e-04 | 31 | 236 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 5.39e-04 | 14 | 236 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.95e-04 | 33 | 236 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | phosphatidylcholine binding | 6.68e-04 | 34 | 236 | 4 | GO:0031210 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B4 COQ8B PEX1 RECQL4 AFG3L2 DNAH8 DNAH2 ATP13A5 CCT2 ABCC6 ATAD3B ATAD3A MACF1 DDX3Y | 8.08e-04 | 441 | 236 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 8.22e-04 | 4 | 236 | 2 | GO:0005219 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT1 PCDH11X FAT4 DSCAM FAT3 PCDH11Y PCDHA7 CELSR2 HMCN1 TENM3 DCHS1 PCDH7 | 1.98e-06 | 187 | 239 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | Wnt signaling pathway, planar cell polarity pathway | 3.25e-06 | 55 | 239 | 7 | GO:0060071 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ABL1 ITGA4 ITGAX STAT5A STAT5B ITPKB STK10 FAT1 PCDH11X COL14A1 GNAS ALOX12 FLNA FAT4 DSCAM FAT3 WNT7B PCDH11Y PCDHA7 CBFB CELSR2 HMCN1 TENM3 DCHS1 LRP6 LRP5 UBASH3B PCDH7 CRB2 EPHA7 | 7.97e-06 | 1077 | 239 | 30 | GO:0098609 |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 8.08e-06 | 146 | 239 | 10 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 8.58e-06 | 147 | 239 | 10 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 9.67e-06 | 149 | 239 | 10 | GO:0051282 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | INPPL1 ITGAX FREM1 RYR2 MKS1 STAT5A STAT6 NRP2 ITPR1 ESRP2 CFLAR CSRNP1 FAT1 RECQL4 FLRT2 GNAS FLNA FAT4 SLC4A7 DSCAM IFT57 FAT3 WNT7B KAT6A MUC19 CHSY1 TENM3 DCHS1 LRP6 LRP5 DNAAF1 CRB2 MYBPC3 | 1.13e-05 | 1269 | 239 | 33 | GO:0009887 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | ABL1 INPPL1 GCK ITGA4 RYR2 RYR3 C2CD5 STAT5A STAT5B STAT6 ITPR1 ITPR3 EFTUD2 CFLAR FAT1 RRAGD AFG3L2 XRN1 PLCD1 PLCG1 GNAS BAG6 CACNA1B FLNA RANGAP1 HTR2C RRM2B PDPK2P RETN AKAP9 LRP6 LRP5 EDEM1 | 1.19e-05 | 1272 | 239 | 33 | GO:1901698 |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.22e-05 | 153 | 239 | 10 | GO:0051208 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | ITGA4 FAT1 PCDH11X FAT4 DSCAM FAT3 PCDH11Y PCDHA7 CELSR2 HMCN1 TENM3 DCHS1 PCDH7 CRB2 | 1.86e-05 | 313 | 239 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | ABL1 INPPL1 GCK ITGA4 RYR2 RYR3 C2CD5 STAT5A STAT5B STAT6 ITPR1 ITPR3 CFLAR FAT1 RRAGD AFG3L2 XRN1 GNAS FLNA RANGAP1 HTR2C PDPK2P AKAP9 | 2.34e-05 | 752 | 239 | 23 | GO:1901699 |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 3.10e-05 | 77 | 239 | 7 | GO:0035567 | |
| GeneOntologyBiologicalProcess | inositol trisphosphate metabolic process | 3.72e-05 | 17 | 239 | 4 | GO:0032957 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | ABL1 RYR2 RYR3 ITPR1 ITPR3 PLCD1 PLCG1 CACNA1B FLNA HTR2C UBASH3B | 4.82e-05 | 217 | 239 | 11 | GO:0097553 |
| GeneOntologyBiologicalProcess | maintenance of location in cell | ABL1 RYR2 RYR3 ITPR1 ITPR3 PLCD1 PLCG1 FLNA RANGAP1 HTR2C AKAP9 UBASH3B | 5.27e-05 | 259 | 239 | 12 | GO:0051651 |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway, planar cell polarity pathway | 5.94e-05 | 19 | 239 | 4 | GO:2000095 | |
| GeneOntologyBiologicalProcess | actin filament-based process | ABL1 INPPL1 SPTBN2 ARFIP2 RYR2 CFLAR FAT1 SCN9A IQSEC1 SETD3 FLNA FLNB FLNC ESPNL MYOM3 OBSL1 ARFGEF1 AKAP9 NUP155 HMCN1 RHPN2 TBCK CGNL1 DAAM1 MYBPC3 | 6.19e-05 | 912 | 239 | 25 | GO:0030029 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | ABL1 ITGAX RYR2 MKS1 STAT5A NRP2 ESRP2 FAT1 CC2D2A ALOX12 FLNA FAT4 IFT57 WNT7B DCHS1 LRP6 LRP5 MACF1 DNAAF1 CRB2 EPHA7 MYBPC3 | 6.58e-05 | 750 | 239 | 22 | GO:0048729 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 8.89e-05 | 63 | 239 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.74e-04 | 10 | 239 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | maintenance of location | ABL1 RYR2 RYR3 STAT5A STAT5B ITPR1 ITPR3 PLCD1 PLCG1 FLNA RANGAP1 HTR2C AKAP9 UBASH3B | 2.29e-04 | 396 | 239 | 14 | GO:0051235 |
| Domain | ConA-like_dom | CMYA5 RYR2 RYR3 NRP2 FAT1 COL21A1 COL14A1 HERC1 FAT4 TRIM51 FAT3 TRIM43 TRIM43B CELSR2 CRB2 | 1.11e-07 | 219 | 233 | 15 | IPR013320 |
| Domain | RIH_assoc-dom | 3.47e-07 | 6 | 233 | 4 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.47e-07 | 6 | 233 | 4 | PF08709 | |
| Domain | RIH_assoc | 3.47e-07 | 6 | 233 | 4 | PF08454 | |
| Domain | RIH_dom | 3.47e-07 | 6 | 233 | 4 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.47e-07 | 6 | 233 | 4 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 3.47e-07 | 6 | 233 | 4 | IPR015925 | |
| Domain | - | 3.47e-07 | 6 | 233 | 4 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 3.47e-07 | 6 | 233 | 4 | PF01365 | |
| Domain | Cadherin | FREM1 FAT1 PCDH11X FAT4 FAT3 PCDH11Y PCDHA7 CELSR2 DCHS1 PCDH7 | 2.26e-06 | 118 | 233 | 10 | IPR002126 |
| Domain | FN3_dom | IGFN1 CMYA5 TRIL LRFN2 COL14A1 FLRT2 FLNC DSCAM MYOM3 OBSL1 CSF2RA EPHA7 MYBPC3 | 2.34e-06 | 209 | 233 | 13 | IPR003961 |
| Domain | FN3 | IGFN1 CMYA5 LRFN2 COL14A1 FLRT2 FLNC DSCAM MYOM3 OBSL1 CSF2RA EPHA7 MYBPC3 | 3.74e-06 | 185 | 233 | 12 | SM00060 |
| Domain | MIR | 4.67e-06 | 10 | 233 | 4 | PF02815 | |
| Domain | MIR_motif | 4.67e-06 | 10 | 233 | 4 | IPR016093 | |
| Domain | MIR | 4.67e-06 | 10 | 233 | 4 | PS50919 | |
| Domain | MIR | 4.67e-06 | 10 | 233 | 4 | SM00472 | |
| Domain | Laminin_G | 7.52e-06 | 58 | 233 | 7 | IPR001791 | |
| Domain | ACTININ_2 | 8.11e-06 | 23 | 233 | 5 | PS00020 | |
| Domain | ACTININ_1 | 8.11e-06 | 23 | 233 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 8.11e-06 | 23 | 233 | 5 | IPR001589 | |
| Domain | Cadherin_CS | 9.06e-06 | 109 | 233 | 9 | IPR020894 | |
| Domain | CADHERIN_1 | 1.22e-05 | 113 | 233 | 9 | PS00232 | |
| Domain | Cadherin | 1.22e-05 | 113 | 233 | 9 | PF00028 | |
| Domain | CADHERIN_2 | 1.31e-05 | 114 | 233 | 9 | PS50268 | |
| Domain | - | 1.31e-05 | 114 | 233 | 9 | 2.60.40.60 | |
| Domain | CA | 1.40e-05 | 115 | 233 | 9 | SM00112 | |
| Domain | Cadherin-like | 1.50e-05 | 116 | 233 | 9 | IPR015919 | |
| Domain | Protocadherin | 1.88e-05 | 5 | 233 | 3 | PF08374 | |
| Domain | Protocadherin | 1.88e-05 | 5 | 233 | 3 | IPR013585 | |
| Domain | fn3 | IGFN1 CMYA5 LRFN2 COL14A1 FLRT2 DSCAM MYOM3 OBSL1 EPHA7 MYBPC3 | 3.72e-05 | 162 | 233 | 10 | PF00041 |
| Domain | WD40_repeat_CS | 4.13e-05 | 164 | 233 | 10 | IPR019775 | |
| Domain | FN3 | IGFN1 CMYA5 LRFN2 COL14A1 FLRT2 DSCAM MYOM3 OBSL1 CSF2RA EPHA7 MYBPC3 | 4.22e-05 | 199 | 233 | 11 | PS50853 |
| Domain | STAT_TF_DNA-bd_sub | 6.46e-05 | 7 | 233 | 3 | IPR012345 | |
| Domain | STAT | 6.46e-05 | 7 | 233 | 3 | IPR001217 | |
| Domain | STAT_int | 6.46e-05 | 7 | 233 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.46e-05 | 7 | 233 | 3 | IPR013801 | |
| Domain | STAT_bind | 6.46e-05 | 7 | 233 | 3 | PF02864 | |
| Domain | STAT_int | 6.46e-05 | 7 | 233 | 3 | PF02865 | |
| Domain | - | 6.46e-05 | 7 | 233 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.46e-05 | 7 | 233 | 3 | PF01017 | |
| Domain | - | 6.46e-05 | 7 | 233 | 3 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 6.46e-05 | 7 | 233 | 3 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 6.46e-05 | 7 | 233 | 3 | IPR015988 | |
| Domain | - | 6.46e-05 | 7 | 233 | 3 | 2.60.40.630 | |
| Domain | EF-hand-dom_pair | NCALD RYR2 RYR3 STAT5A STAT5B STAT6 HPCAL1 SCN9A PLCD1 PLCG1 CACNA1B PHF24 MACF1 | 6.82e-05 | 287 | 233 | 13 | IPR011992 |
| Domain | WD40_repeat_dom | LRWD1 WDR25 EDC4 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 TENM3 | 9.64e-05 | 297 | 233 | 13 | IPR017986 |
| Domain | STAT_TF_alpha | 1.02e-04 | 8 | 233 | 3 | IPR013800 | |
| Domain | LAM_G_DOMAIN | 1.04e-04 | 38 | 233 | 5 | PS50025 | |
| Domain | Laminin_G_2 | 1.33e-04 | 40 | 233 | 5 | PF02210 | |
| Domain | WD40 | LRWD1 WDR25 EDC4 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 1.45e-04 | 268 | 233 | 12 | SM00320 |
| Domain | LRP5/6 | 1.55e-04 | 2 | 233 | 2 | IPR017049 | |
| Domain | CH | 1.58e-04 | 65 | 233 | 6 | SM00033 | |
| Domain | EGF-like_Ca-bd_dom | 1.65e-04 | 124 | 233 | 8 | IPR001881 | |
| Domain | WD40_repeat | LRWD1 WDR25 EDC4 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 1.66e-04 | 272 | 233 | 12 | IPR001680 |
| Domain | SPRY | 1.75e-04 | 94 | 233 | 7 | PF00622 | |
| Domain | SPRY_dom | 1.75e-04 | 94 | 233 | 7 | IPR003877 | |
| Domain | EGF | 1.86e-04 | 235 | 233 | 11 | SM00181 | |
| Domain | B30.2/SPRY | 1.87e-04 | 95 | 233 | 7 | IPR001870 | |
| Domain | B302_SPRY | 1.87e-04 | 95 | 233 | 7 | PS50188 | |
| Domain | WD_REPEATS_1 | LRWD1 WDR25 EDC4 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 2.03e-04 | 278 | 233 | 12 | PS00678 |
| Domain | WD_REPEATS_2 | LRWD1 WDR25 EDC4 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 2.10e-04 | 279 | 233 | 12 | PS50082 |
| Domain | WD_REPEATS_REGION | LRWD1 WDR25 EDC4 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 2.10e-04 | 279 | 233 | 12 | PS50294 |
| Domain | LamG | 2.11e-04 | 44 | 233 | 5 | SM00282 | |
| Domain | IG_FLMN | 2.16e-04 | 10 | 233 | 3 | SM00557 | |
| Domain | CH | 2.38e-04 | 70 | 233 | 6 | PF00307 | |
| Domain | EGF_CA | 2.42e-04 | 99 | 233 | 7 | PS01187 | |
| Domain | - | IGFN1 CMYA5 LRFN2 PIGR COL14A1 FLRT2 TAPBP IGSF3 FLNA FLNB FLNC DSCAM MYOM3 OBSL1 PKHD1L1 CSF2RA HMCN1 IGSF1 EPHA7 MYBPC3 | 2.56e-04 | 663 | 233 | 20 | 2.60.40.10 |
| Domain | ASX_HYDROXYL | 2.57e-04 | 100 | 233 | 7 | PS00010 | |
| Domain | - | 2.57e-04 | 71 | 233 | 6 | 1.10.418.10 | |
| Domain | Filamin | 2.94e-04 | 11 | 233 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.94e-04 | 11 | 233 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.94e-04 | 11 | 233 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.94e-04 | 11 | 233 | 3 | IPR017868 | |
| Domain | CH | 3.00e-04 | 73 | 233 | 6 | PS50021 | |
| Domain | EGF-like_dom | 3.06e-04 | 249 | 233 | 11 | IPR000742 | |
| Domain | CH-domain | 3.47e-04 | 75 | 233 | 6 | IPR001715 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.68e-04 | 106 | 233 | 7 | IPR000152 | |
| Domain | C8 | 3.88e-04 | 12 | 233 | 3 | PF08742 | |
| Domain | TIL | 3.88e-04 | 12 | 233 | 3 | PF01826 | |
| Domain | WD40 | LRWD1 WDR25 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 4.27e-04 | 259 | 233 | 11 | PF00400 |
| Domain | EGF-like_CS | 4.56e-04 | 261 | 233 | 11 | IPR013032 | |
| Domain | - | NCALD RYR2 RYR3 STAT5A STAT5B STAT6 HPCAL1 PLCD1 PLCG1 PHF24 MACF1 | 4.56e-04 | 261 | 233 | 11 | 1.10.238.10 |
| Domain | Ryanodine_rcpt | 4.61e-04 | 3 | 233 | 2 | IPR003032 | |
| Domain | DUF3523 | 4.61e-04 | 3 | 233 | 2 | IPR021911 | |
| Domain | InsP3_rcpt-bd | 4.61e-04 | 3 | 233 | 2 | IPR000493 | |
| Domain | Ryanrecept_TM4-6 | 4.61e-04 | 3 | 233 | 2 | IPR009460 | |
| Domain | RyR | 4.61e-04 | 3 | 233 | 2 | PF02026 | |
| Domain | ALG1-like | 4.61e-04 | 3 | 233 | 2 | IPR026051 | |
| Domain | DUF3523 | 4.61e-04 | 3 | 233 | 2 | PF12037 | |
| Domain | RR_TM4-6 | 4.61e-04 | 3 | 233 | 2 | PF06459 | |
| Domain | Ryan_recept | 4.61e-04 | 3 | 233 | 2 | IPR013333 | |
| Domain | Unchr_dom_Cys-rich | 5.00e-04 | 13 | 233 | 3 | IPR014853 | |
| Domain | C8 | 5.00e-04 | 13 | 233 | 3 | SM00832 | |
| Domain | EGF_2 | 5.17e-04 | 265 | 233 | 11 | PS01186 | |
| Domain | Ig-like_fold | IGFN1 CMYA5 LRFN2 PIGR COL14A1 FLRT2 TAPBP IGSF3 FLNA FLNB FLNC DSCAM MYOM3 OBSL1 PKHD1L1 CSF2RA HMCN1 IGSF1 EPHA7 MYBPC3 | 5.69e-04 | 706 | 233 | 20 | IPR013783 |
| Domain | Ion_trans_dom | 5.71e-04 | 114 | 233 | 7 | IPR005821 | |
| Domain | Ion_trans | 5.71e-04 | 114 | 233 | 7 | PF00520 | |
| Domain | TIL_dom | 6.30e-04 | 14 | 233 | 3 | IPR002919 | |
| Domain | EGF_3 | 7.63e-04 | 235 | 233 | 10 | PS50026 | |
| Domain | Growth_fac_rcpt_ | 7.75e-04 | 156 | 233 | 8 | IPR009030 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | RYR2 RYR3 ITPKB ITPR1 ITPR3 PLCD1 PLCG1 GNAS CACNA1B HTR2C CAMK4 | 1.97e-05 | 178 | 182 | 11 | M2890 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.08e-05 | 5 | 182 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 4.11e-05 | 6 | 182 | 3 | M47960 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.95e-05 | 19 | 182 | 4 | M47760 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.22e-04 | 147 | 182 | 9 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.50e-04 | 151 | 182 | 9 | M39329 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRWD1 ABL1 PCNX3 PPRC1 INPPL1 FYCO1 EDC4 ITPR3 ESRP2 STK10 TLK1 FAT1 ZNRF3 PLCG1 GPC2 DENND5A HERC1 ZC3H7B IGSF3 SMG6 PITPNM2 FLNA FLNC WNT7B RTTN KAT6A KSR2 MYOM3 ARFGEF2 CHSY1 LMNB2 MICALL1 CELSR2 STEAP3 LRP5 TNK2 | 1.29e-14 | 1105 | 241 | 36 | 35748872 |
| Pubmed | ARFIP2 RYR2 MKS1 EFTUD2 FAT1 XRN1 ZNF638 FLRT2 IGSF3 AVEN FAT4 SLC4A7 DSCAM CAMK4 ARFGEF2 ARFGEF1 CCT2 PKHD1L1 GTF2I NUP155 TENM3 STEAP3 PRKCH CGNL1 PEAK1 PCDH7 XPO7 | 7.91e-12 | 777 | 241 | 27 | 35844135 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | IMPDH2 ACLY PSMB6 PEX1 EDC4 NCAPG2 ITPR3 ZNRF3 TAPBP BAG6 ALG1 FLNA RANGAP1 COPA TTI2 DNAH2 OBSL1 ARFGEF1 TTC27 CHSY1 SAMHD1 LMNB2 PDIA6 ATAD3B NUP155 ATAD3A LRP6 XPO7 | 1.18e-10 | 942 | 241 | 28 | 31073040 |
| Pubmed | IMPDH2 ACLY SPTBN2 EDC4 ITPR3 UTP15 SUPT5H XRN1 ZNF638 CLUH FLNA FLNB FLNC RANGAP1 COPA CCT2 LMNB2 MSH6 GTF2I NUP155 ATAD3A MACF1 XPO7 | 2.35e-10 | 653 | 241 | 23 | 22586326 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ACLY NCAPG2 C2CD5 ITPR3 SUPT5H AFG3L2 PTRH1 XRN1 PLCG1 GNAS CLUH BAG6 ALG1 FLNA FLNB FLNC RRAS2 VPS26B OBSL1 TTC27 SAMHD1 MSH6 PDIA6 GTF2I NUP155 ATAD3A EDEM1 PPP6R2 | 2.51e-10 | 974 | 241 | 28 | 28675297 |
| Pubmed | NCALD ACADS PSMB6 EDC4 RYR2 ITPR1 HPCAL1 AFG3L2 XRN1 IQSEC1 TIMM44 IGSF3 PITPNM2 CACNA1B FLNA FLNB RANGAP1 SLC4A7 SLC4A8 CAMK4 TACC2 PITPNM1 ATAD3B CELSR2 ATAD3A MACF1 DAAM1 PEAK1 PPP6R2 ELP4 | 4.38e-10 | 1139 | 241 | 30 | 36417873 | |
| Pubmed | 2.25e-09 | 4 | 241 | 4 | 11739414 | ||
| Pubmed | IMPDH2 SPTBN2 NCAPG2 C2CD5 ITPR1 ITPR3 EFTUD2 UTP15 ERAP2 AFG3L2 COL14A1 GNAS TIMM44 CLUH BAG6 RANGAP1 SLC4A7 OBSL1 LMNB2 MICALL1 PDIA6 ATAD3B PAXBP1 AKAP9 NUP155 ATAD3A STEAP3 MACF1 DAAM1 PEAK1 PPP6R2 PCDH7 EPHA7 | 4.03e-09 | 1487 | 241 | 33 | 33957083 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LRWD1 ACLY C2CD5 EFTUD2 STK10 TLK1 IQSEC1 ZNF638 CLUH BAG6 FLNA RANGAP1 COPA ARID4A ARFGEF2 MICALL1 PITPNM1 MSH6 PDIA6 GTF2I PAXBP1 PROSER2 PCDH7 | 5.97e-09 | 774 | 241 | 23 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | LRWD1 IMPDH2 ACLY PSMB6 NCAPG2 EFTUD2 UTP15 RECQL4 A2ML1 AFG3L2 XRN1 IQSEC1 ZNF638 PLCG1 TIMM44 BAG6 FLNA FLNB FLNC RRAS2 RANGAP1 COPA TTC27 CCT2 LMNB2 MSH6 PDIA6 GTF2I NUP155 ATAD3A MACF1 | 6.00e-09 | 1353 | 241 | 31 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | LRWD1 IMPDH2 ACLY SPTBN2 EDC4 ITPR3 EFTUD2 SUPT5H AFG3L2 ZNF638 GNAS BAG6 FLNA FLNB FLNC RRAS2 RANGAP1 COPA OBSL1 CCT2 LMNB2 PDIA6 NUP155 ATAD3A MACF1 XPO7 | 1.46e-08 | 1024 | 241 | 26 | 24711643 |
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.34e-08 | 6 | 241 | 4 | 25966694 | |
| Pubmed | 3.34e-08 | 6 | 241 | 4 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.34e-08 | 6 | 241 | 4 | 16844763 | |
| Pubmed | INPPL1 ITGA4 C2CD5 STK10 AFG3L2 NHS SLC4A7 ATAD3B NUP155 CELSR2 TENM3 STEAP3 MACF1 DAAM1 PEAK1 PCDH7 | 5.00e-08 | 421 | 241 | 16 | 36976175 | |
| Pubmed | IMPDH2 ACLY FYCO1 ITGA4 EDC4 ITGAX NCAPG2 ITPR1 ITPR3 EFTUD2 RECQL4 XRN1 IQSEC1 GNAS BAG6 ALG1 FLNA COPA MPDU1 ARFGEF2 CHSY1 CBFB GTF2I NUP155 TNK2 DDX3Y DAAM1 | 5.20e-08 | 1168 | 241 | 27 | 19946888 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK11 ACLY SPTBN2 COQ8B CSMD2 ESRP2 RECQL4 FLNB SIN3B FAT4 RANGAP1 TTI2 MYOM3 DNAH2 MUC19 SAMHD1 LMNB2 TRIM43B MSH6 FRY ELP4 | 5.60e-08 | 736 | 241 | 21 | 29676528 |
| Pubmed | RASGRP4 IMPDH2 ITPR3 GNAS BAG6 CACNA1B FLNA SLC4A7 COPA PDIA6 TENM3 MACF1 PRKCH PEAK1 | 6.79e-08 | 322 | 241 | 14 | 26514267 | |
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 16059920 | ||
| Pubmed | 7.74e-08 | 7 | 241 | 4 | 11860456 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | INPPL1 SPTBN2 PSMB6 ARFIP2 XRN1 NHS FLNA FLNB RANGAP1 SLC4A7 ABLIM3 MICALL1 TENM3 STEAP3 MACF1 DAAM1 PEAK1 ELP4 | 1.03e-07 | 565 | 241 | 18 | 25468996 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | IMPDH2 ACLY INPPL1 PSMB6 EDC4 CMYA5 ARFIP2 STAT5B STAT6 EFTUD2 SUPT5H PLCG1 HERC1 CLUH BAG6 FLNA FLNB FLNC RANGAP1 COPA ARFGEF2 CCT2 SAMHD1 MSH6 PDIA6 GTF2I NUP155 MACF1 ELP4 XPO7 | 1.09e-07 | 1455 | 241 | 30 | 22863883 |
| Pubmed | IMPDH2 PEX1 NCAPG2 STAT5B ITPR1 SUPT5H RECQL4 AFG3L2 XRN1 ZNF638 DENND5A ZC3H7B ALG1 OBSL1 PDIA6 NUP155 RHPN2 EDEM1 PPP6R2 | 1.70e-07 | 650 | 241 | 19 | 38777146 | |
| Pubmed | 1.73e-07 | 87 | 241 | 8 | 24169447 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | WDR25 STAT5B ITPKB STK10 TLK1 LRFN2 HPCAL1 ZNF638 PLCG1 DENND5A GNAS SMG6 PITPNM2 NSUN5P1 FLNB PTBP2 WNT7B PCDH11Y KAT6A KSR2 ATAD3B GTF2I ATAD3A SETBP1 TBCK LRP5 MACF1 TNK2 DAAM1 XPO7 | 1.79e-07 | 1489 | 241 | 30 | 28611215 |
| Pubmed | IMPDH2 DOCK11 SPTBN2 FYCO1 EDC4 EFTUD2 IQSEC1 TAF5 SMG6 SIN3B RANGAP1 SLC4A8 DSCAM KSR2 LMNB2 ABLIM3 FRY AKAP9 CELSR2 DCHS1 MACF1 UBASH3B PPP6R2 | 3.06e-07 | 963 | 241 | 23 | 28671696 | |
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 12393796 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 11153914 | ||
| Pubmed | 3.29e-07 | 3 | 241 | 3 | 11252955 | ||
| Pubmed | Stat5a regulates T helper cell differentiation by several distinct mechanisms. | 3.29e-07 | 3 | 241 | 3 | 11290598 | |
| Pubmed | ATP8B4 SPTBN2 C2CD5 EFTUD2 TLK1 FLRT2 SIN3B SLC4A8 ABLIM3 WDFY4 ATAD3B ATAD3A MACF1 CGNL1 PEAK1 PPP6R2 | 4.20e-07 | 493 | 241 | 16 | 15368895 | |
| Pubmed | 5.85e-07 | 24 | 241 | 5 | 10843712 | ||
| Pubmed | DDAH2 IMPDH2 ACLY INPPL1 PSMB6 ITGA4 STAT5B EFTUD2 SUPT5H BAG6 FLNA FLNB FLNC COPA CCT2 PDIA6 NUP155 ATAD3A MACF1 | 6.06e-07 | 707 | 241 | 19 | 19738201 | |
| Pubmed | PPRC1 PSMB6 PEX1 C2CD5 STAT6 ITPR1 POLR3D RRAGD ZNF638 PLCG1 HERC1 TAPBP FLNA FLNB SLC4A7 PTBP2 TACC2 CUBN ABLIM3 WDFY4 PAXBP1 MACF1 DDX3Y PEAK1 | 6.47e-07 | 1084 | 241 | 24 | 11544199 | |
| Pubmed | Assembly of the WHIP-TRIM14-PPP6C Mitochondrial Complex Promotes RIG-I-Mediated Antiviral Signaling. | ACLY PSMB6 EFTUD2 FAT1 PLCG1 TIMM44 BAG6 RANGAP1 TTC27 SAMHD1 MICALL1 MSH6 PDIA6 | 6.59e-07 | 332 | 241 | 13 | 29053956 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | IMPDH2 EDC4 EFTUD2 SUPT5H ZNF638 FLNA FLNB RANGAP1 COPA CCT2 SAMHD1 MSH6 GTF2I | 6.59e-07 | 332 | 241 | 13 | 32786267 |
| Pubmed | 7.14e-07 | 11 | 241 | 4 | 36579465 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | TLK1 RRAGD ATP6V1C2 TAF5 ARID4A ARFGEF2 ARFGEF1 PAXBP1 RHPN2 XPO7 | 7.80e-07 | 186 | 241 | 10 | 33637726 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP8B4 IMPDH2 ACLY EDC4 CMYA5 EFTUD2 UTP15 SUPT5H CC2D2A PLCG1 GNAS TIMM44 CLUH BAG6 FLNA FLNB RANGAP1 COPA CCT2 SAMHD1 LMNB2 MSH6 PDIA6 GTF2I PAXBP1 NUP155 ATAD3A PEAK1 | 7.81e-07 | 1425 | 241 | 28 | 30948266 |
| Pubmed | IMPDH2 INPPL1 PSMB6 AFG3L2 XRN1 GNAS BAG6 FLNA FLNB COPA DHRS4L2 SAMHD1 MSH6 ATAD3B GTF2I NUP155 | 1.20e-06 | 534 | 241 | 16 | 35032548 | |
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 1.31e-06 | 4 | 241 | 3 | 22802962 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.31e-06 | 4 | 241 | 3 | 23413940 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 9607712 | ||
| Pubmed | STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia. | 1.31e-06 | 4 | 241 | 3 | 23458731 | |
| Pubmed | Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. | 1.31e-06 | 4 | 241 | 3 | 16365403 | |
| Pubmed | 1.31e-06 | 4 | 241 | 3 | 28422733 | ||
| Pubmed | ACLY EDC4 EFTUD2 TIMM44 BAG6 FLNA FLNB RANGAP1 COPA PTBP2 CCT2 SAMHD1 LMNB2 PDIA6 GTF2I NUP155 ATAD3A | 2.70e-06 | 638 | 241 | 17 | 33239621 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SPTBN2 STK10 FAT1 PCDH11X IGSF3 SLC4A7 SLC4A8 ARFGEF2 ARFGEF1 MICALL1 CELSR2 RHPN2 STEAP3 PEAK1 PCDH7 EPHA7 | 2.70e-06 | 569 | 241 | 16 | 30639242 |
| Pubmed | IMPDH2 SPTBN2 PSMB6 COQ8B EDC4 NCAPG2 ITPR1 ITPR3 EFTUD2 AFG3L2 GNAS TIMM44 BAG6 FLNA FLNB RANGAP1 COPA TTI2 TTC27 CCT2 SAMHD1 MSH6 PDIA6 ATAD3B GTF2I NUP155 ATAD3A | 2.99e-06 | 1440 | 241 | 27 | 30833792 | |
| Pubmed | STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus. | 3.25e-06 | 5 | 241 | 3 | 32985505 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 22234689 | ||
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 12006559 | ||
| Pubmed | Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. | 3.25e-06 | 5 | 241 | 3 | 17227909 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 17360453 | ||
| Pubmed | The Current STATus of lymphocyte signaling: new roles for old players. | 3.25e-06 | 5 | 241 | 3 | 19362457 | |
| Pubmed | 3.25e-06 | 5 | 241 | 3 | 19366992 | ||
| Pubmed | IMPDH2 ACADS ACLY PSMB6 NRP2 EFTUD2 GNAS TAPBP FLNA FLNB COPA WNT7B CCT2 SAMHD1 LMNB2 PMEL PDIA6 DDX3Y PPP6R2 | 3.90e-06 | 803 | 241 | 19 | 36517590 | |
| Pubmed | IMPDH2 SPTBN2 PSMB6 EFTUD2 FLNA FLNB FLNC COPA CCT2 LMNB2 GTF2I ATAD3A | 4.32e-06 | 334 | 241 | 12 | 30425250 | |
| Pubmed | SPTBN2 ITPR1 ITPR3 SUPT5H AFG3L2 ZNF638 NHS HERC1 RANGAP1 COPA IFT57 TTC27 CCT2 CNNM1 MSH6 PDIA6 AKAP9 NUP155 LRP6 PEAK1 PPP6R2 PCDH7 | 4.61e-06 | 1049 | 241 | 22 | 27880917 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PECR IMPDH2 SUPT5H PLCG1 FLNA FLNB FLNC COPA VPS26B CCT2 UBASH3B XPO7 | 5.82e-06 | 344 | 241 | 12 | 30333137 |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 6.11e-06 | 139 | 241 | 8 | 25476789 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 6.38e-06 | 18 | 241 | 4 | 12119179 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 6.38e-06 | 38 | 241 | 5 | 30786075 | |
| Pubmed | Sensitivity and resistance to regulation by IL-4 during Th17 maturation. | 6.47e-06 | 6 | 241 | 3 | 21949021 | |
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 6.47e-06 | 6 | 241 | 3 | 14704793 | |
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 6.47e-06 | 6 | 241 | 3 | 21762810 | |
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 17182563 | ||
| Pubmed | 6.47e-06 | 6 | 241 | 3 | 10675904 | ||
| Pubmed | Macrophage Wnt7b is critical for kidney repair and regeneration. | 6.47e-06 | 6 | 241 | 3 | 20160075 | |
| Pubmed | 6.95e-06 | 101 | 241 | 7 | 9872452 | ||
| Pubmed | IMPDH2 ACLY INPPL1 PSMB6 ITPR3 EFTUD2 ERAP2 AFG3L2 XRN1 NHS GNAS FLNA RRAS2 RANGAP1 COPA TTC27 CCT2 SAMHD1 CBFB PAXBP1 AKAP9 ATAD3A DDX3Y PPP6R2 | 7.13e-06 | 1247 | 241 | 24 | 27684187 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 7.29e-06 | 67 | 241 | 6 | 21875946 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | IMPDH2 SPTBN2 ZKSCAN8 ZSCAN25 EFTUD2 SUPT5H IQSEC1 ZNF638 GPC2 FLNC RANGAP1 COPA RBM45 PTBP2 MPDU1 LMNB2 MSH6 PDIA6 PAXBP1 ATAD3A MACF1 DDX3Y | 7.50e-06 | 1082 | 241 | 22 | 38697112 |
| Pubmed | IMPDH2 ACLY EFTUD2 GNAS FLNA FLNB FLNC RRAS2 SLC4A7 COPA MPDU1 PDIA6 ATAD3B NUP155 | 8.36e-06 | 484 | 241 | 14 | 31995728 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 8.44e-06 | 104 | 241 | 7 | 31240132 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | IMPDH2 ACLY EDC4 EFTUD2 AFG3L2 XRN1 ZNF638 PLCG1 FLNA SIN3B RANGAP1 CAMK4 CCT2 TACC2 MSH6 PDIA6 GTF2I MACF1 CGNL1 PPP6R2 | 9.41e-06 | 934 | 241 | 20 | 33916271 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ACLY ARFIP2 NRP2 ITPR1 EFTUD2 FAT1 IQSEC1 GNAS TAPBP BAG6 ALG1 FLNA FLNB FLNC RRAS2 SLC4A7 COPA CCT2 ALG1L2 PDIA6 ATAD3B AKAP9 NUP155 CELSR2 ATAD3A XPO7 | 1.03e-05 | 1451 | 241 | 26 | 30550785 |
| Pubmed | IMPDH2 ACLY AFG3L2 XRN1 TIMM44 FLNB RANGAP1 COPA CCT2 MICALL1 PDIA6 NUP155 ATAD3A LRP6 MACF1 PEAK1 PCDH7 | 1.05e-05 | 708 | 241 | 17 | 39231216 | |
| Pubmed | 1.13e-05 | 7 | 241 | 3 | 20118929 | ||
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.13e-05 | 7 | 241 | 3 | 22510986 | |
| Pubmed | 1.13e-05 | 7 | 241 | 3 | 15923619 | ||
| Pubmed | 1.13e-05 | 7 | 241 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 1.13e-05 | 7 | 241 | 3 | 12039028 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 1.13e-05 | 7 | 241 | 3 | 12634107 | |
| Pubmed | 1.13e-05 | 7 | 241 | 3 | 16076904 | ||
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 1.13e-05 | 7 | 241 | 3 | 24058793 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 1.13e-05 | 7 | 241 | 3 | 10526573 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | IMPDH2 ACLY CMYA5 C2CD5 EFTUD2 CFLAR TLK1 PIGR GNAS HERC1 BAG6 RANGAP1 SLC4A7 MPDU1 TTC27 MICALL1 MSH6 PDIA6 ATAD3B GTF2I RHPN2 ATAD3A EDEM1 XPO7 | 1.15e-05 | 1284 | 241 | 24 | 17353931 |
| Pubmed | ARFIP2 ITPR1 ITPR3 XRN1 FLNA FLNB FLNC RANGAP1 SLC4A7 ARID4A LMNB2 PITPNM1 NUP155 STEAP3 ELP4 | 1.17e-05 | 568 | 241 | 15 | 37774976 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | DDAH2 ARFIP2 C2CD5 STK10 HPCAL1 HERC1 TAPBP IGSF3 RRAS2 RRM2B RTTN MICALL1 CNNM1 TENM3 MACF1 PEAK1 EPHA7 | 1.29e-05 | 719 | 241 | 17 | 35337019 |
| Pubmed | PEX1 BCAT2 FYCO1 ARFIP2 ITPR1 ITPR3 BAG6 SLC4A7 VPS26B ARFGEF2 ARFGEF1 NUP155 STEAP3 PCDH7 | 1.31e-05 | 504 | 241 | 14 | 34432599 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | PCNX3 ITGA4 C2CD5 NRP2 STK10 FLRT2 GNAS IGSF3 SLC4A7 MICALL1 STEAP3 PEAK1 | 1.46e-05 | 377 | 241 | 12 | 38117590 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACLY PSMB6 FYCO1 EDC4 EFTUD2 GNAS FLNA FLNB FLNC RRAS2 COPA MUC19 CCT2 MSH6 PDIA6 AKAP9 MACF1 PEAK1 | 1.55e-05 | 807 | 241 | 18 | 30575818 |
| Pubmed | LRWD1 IMPDH2 ACLY ITPR3 EFTUD2 UTP15 SUPT5H GNAS FLNA FLNB RANGAP1 COPA LMNB2 NUP155 ATAD3A MACF1 | 1.71e-05 | 660 | 241 | 16 | 32780723 | |
| Pubmed | 1.79e-05 | 8 | 241 | 3 | 23727894 | ||
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 1.79e-05 | 8 | 241 | 3 | 9989503 | |
| Pubmed | MEKK4 signaling regulates filamin expression and neuronal migration. | 1.79e-05 | 8 | 241 | 3 | 17145501 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.79e-05 | 8 | 241 | 3 | 19033399 | |
| Pubmed | ABL1 IMPDH2 ACLY INPPL1 EDC4 CCT2 ATAD3B GTF2I PEAK1 UBASH3B | 1.86e-05 | 266 | 241 | 10 | 19380743 | |
| Interaction | RAC3 interactions | DOCK11 SPTBN2 ARFIP2 C2CD5 ITPR1 FAT1 AFG3L2 NHS FLRT2 GNAS IGSF3 RRAS2 FAT4 SLC4A7 LMNB2 MICALL1 NUP155 TENM3 STEAP3 LRP6 LRP5 MACF1 DAAM1 PEAK1 PCDH7 EPHA7 | 2.54e-08 | 619 | 239 | 26 | int:RAC3 |
| Interaction | TOP3B interactions | LRWD1 ABL1 PCNX3 PPRC1 INPPL1 SPTBN2 FYCO1 EDC4 ITPR3 ESRP2 STK10 TLK1 FAT1 ZNRF3 XRN1 PLCG1 GPC2 DENND5A GNAS HERC1 ZC3H7B IGSF3 SMG6 PITPNM2 FLNA FLNC RRM2B WNT7B RTTN KAT6A KSR2 MYOM3 ARFGEF2 CHSY1 LMNB2 MICALL1 GTF2I CELSR2 ATAD3A STEAP3 LRP5 TNK2 | 8.72e-08 | 1470 | 239 | 42 | int:TOP3B |
| Interaction | RHOB interactions | PCNX3 DOCK11 INPPL1 SPTBN2 C2CD5 STK10 FAT1 AFG3L2 IQSEC1 FLRT2 GNAS HERC1 IGSF3 RRAS2 FAT4 SLC4A7 MICALL1 NUP155 TENM3 RHPN2 ATAD3A STEAP3 LRP6 MACF1 PRKCH DAAM1 PEAK1 PCDH7 EPHA7 | 2.58e-07 | 840 | 239 | 29 | int:RHOB |
| Interaction | ADAMTS13 interactions | 4.93e-07 | 26 | 239 | 6 | int:ADAMTS13 | |
| Interaction | RHOJ interactions | PCNX3 DOCK11 SPTBN2 C2CD5 FAT1 AFG3L2 FLRT2 GNAS IGSF3 RRAS2 SLC4A7 OBSL1 ARFGEF2 LMNB2 MICALL1 ATAD3A STEAP3 LRP6 LRP5 MACF1 DAAM1 PEAK1 PCDH7 EPHA7 | 5.81e-07 | 633 | 239 | 24 | int:RHOJ |
| Interaction | C2CD4B interactions | 7.97e-07 | 44 | 239 | 7 | int:C2CD4B | |
| Interaction | RAC2 interactions | DOCK11 ITGA4 ARFIP2 C2CD5 ITPR1 ITPR3 FAT1 AFG3L2 NHS FLRT2 IGSF3 RRAS2 SLC4A7 ARFGEF2 LMNB2 NUP155 TENM3 STEAP3 LRP5 MACF1 DAAM1 PEAK1 PCDH7 EPHA7 | 1.75e-06 | 674 | 239 | 24 | int:RAC2 |
| Interaction | NXPH2 interactions | 2.21e-06 | 33 | 239 | 6 | int:NXPH2 | |
| Interaction | DCANP1 interactions | 2.28e-06 | 19 | 239 | 5 | int:DCANP1 | |
| Interaction | RHOA interactions | IMPDH2 SPTBN2 C2CD5 ITPR1 ITPR3 STK10 FAT1 AFG3L2 NHS PLCG1 FLRT2 GNAS TIMM44 BAG6 IGSF3 FLNA RRAS2 FAT4 SLC4A7 LMNB2 MICALL1 PITPNM1 NUP155 TENM3 RHPN2 ATAD3A STEAP3 LRP5 MACF1 DAAM1 PEAK1 PCDH7 EPHA7 | 5.62e-06 | 1199 | 239 | 33 | int:RHOA |
| Interaction | SIRT6 interactions | IMPDH2 DOCK11 ACLY FYCO1 C2CD5 ITPR1 ITPR3 EFTUD2 FAT1 SUPT5H BAG6 FLNA FLNB FAT4 FAT3 RRM2B MSH6 GTF2I NUP155 CELSR2 EDEM1 PCDH7 | 6.26e-06 | 628 | 239 | 22 | int:SIRT6 |
| Interaction | UCN3 interactions | 6.36e-06 | 23 | 239 | 5 | int:UCN3 | |
| Interaction | CDC42 interactions | PCNX3 DOCK11 SPTBN2 COQ8B EDC4 NCAPG2 C2CD5 ITPR1 ITPR3 FAT1 RECQL4 AFG3L2 FLRT2 GNAS BAG6 IGSF3 FLNA FLNC RRAS2 FAT4 SLC4A7 COPA KSR2 LMNB2 MICALL1 ATAD3B NUP155 TENM3 ATAD3A STEAP3 LRP5 TNK2 DAAM1 PEAK1 PCDH7 | 6.74e-06 | 1323 | 239 | 35 | int:CDC42 |
| Interaction | RND1 interactions | SPTBN2 ARFIP2 C2CD5 AFG3L2 FLRT2 GNAS RRAS2 SLC4A7 MYOM3 STEAP3 PEAK1 PCDH7 EPHA7 | 8.12e-06 | 246 | 239 | 13 | int:RND1 |
| Interaction | LMBR1L interactions | IMPDH2 ACLY PSMB6 PEX1 EDC4 NCAPG2 ITPR3 ZNRF3 TAPBP BAG6 ALG1 FLNA RANGAP1 COPA TTI2 DNAH2 OBSL1 ARFGEF1 TTC27 CHSY1 SAMHD1 LMNB2 PDIA6 ATAD3B NUP155 ATAD3A LRP6 XPO7 | 8.22e-06 | 946 | 239 | 28 | int:LMBR1L |
| Interaction | XAGE1A interactions | 8.30e-06 | 41 | 239 | 6 | int:XAGE1A | |
| Interaction | PSG8 interactions | 8.30e-06 | 41 | 239 | 6 | int:PSG8 | |
| Interaction | LOC254896 interactions | 1.10e-05 | 43 | 239 | 6 | int:LOC254896 | |
| Interaction | RPS14P3 interactions | 2.38e-05 | 15 | 239 | 4 | int:RPS14P3 | |
| Interaction | PRSS37 interactions | 2.38e-05 | 15 | 239 | 4 | int:PRSS37 | |
| Interaction | RAC1 interactions | DOCK11 INPPL1 SPTBN2 ITGA4 ARFIP2 C2CD5 STK10 FAT1 AFG3L2 NHS FLRT2 GNAS BAG6 IGSF3 FLNA FLNB RRAS2 SLC4A7 LMNB2 MICALL1 NUP155 ATAD3A STEAP3 LRP5 MACF1 DAAM1 PEAK1 PCDH7 EPHA7 | 2.57e-05 | 1063 | 239 | 29 | int:RAC1 |
| Interaction | SIRT7 interactions | IMPDH2 ACLY SPTBN2 EDC4 ITPR3 UTP15 SUPT5H XRN1 ZNF638 CLUH FLNA FLNB FLNC RANGAP1 COPA CCT2 LMNB2 MSH6 GTF2I NUP155 ATAD3A MACF1 XPO7 | 2.84e-05 | 744 | 239 | 23 | int:SIRT7 |
| Interaction | CAPRIN2 interactions | 3.14e-05 | 16 | 239 | 4 | int:CAPRIN2 | |
| Interaction | RHOH interactions | SPTBN2 C2CD5 ESRP2 AFG3L2 FLRT2 GNAS IGSF3 RRAS2 SLC4A7 LMNB2 MICALL1 NUP155 ATAD3A STEAP3 DAAM1 PEAK1 PCDH7 EPHA7 | 4.28e-05 | 512 | 239 | 18 | int:RHOH |
| Interaction | CIT interactions | ZNF142 LRWD1 IMPDH2 SPTBN2 ITGA4 EDC4 CMYA5 ITPR3 EFTUD2 UTP15 SUPT5H ZNF638 GNAS HERC1 TAF5 FLNA FLNB FLNC RANGAP1 DSCAM COPA MPDU1 OBSL1 CCT2 LMNB2 MSH6 PDIA6 ATAD3B GTF2I PAXBP1 AKAP9 NUP155 CELSR2 MACF1 DDX3Y | 4.63e-05 | 1450 | 239 | 35 | int:CIT |
| Interaction | RNF123 interactions | DOCK11 ACLY SPTBN2 COQ8B CSMD2 ESRP2 RECQL4 BAG6 FLNB SIN3B FLNC FAT4 RANGAP1 TTI2 MYOM3 DNAH2 MUC19 SAMHD1 LMNB2 TRIM43B MSH6 FRY ELP4 SMAD9 | 4.88e-05 | 824 | 239 | 24 | int:RNF123 |
| Interaction | INPPL1 interactions | ABL1 ACLY INPPL1 ITGA4 STAT6 AFG3L2 FLNC RRM2B GTF2I PEAK1 UBASH3B | 5.22e-05 | 214 | 239 | 11 | int:INPPL1 |
| Interaction | DKKL1 interactions | 5.38e-05 | 111 | 239 | 8 | int:DKKL1 | |
| Interaction | RHOF interactions | DOCK11 SPTBN2 COQ8B C2CD5 STK10 FAT1 AFG3L2 FLRT2 IGSF3 RRAS2 FAT4 SLC4A7 ARFGEF2 LMNB2 MICALL1 NUP155 ATAD3A STEAP3 MACF1 PEAK1 PCDH7 | 5.60e-05 | 673 | 239 | 21 | int:RHOF |
| Interaction | RCC2 interactions | IMPDH2 DOCK11 ACLY PSMB6 EFTUD2 RECQL4 CLUH OBSL1 CCT2 TACC2 HTRA4 | 5.93e-05 | 217 | 239 | 11 | int:RCC2 |
| Interaction | OBSL1 interactions | ACLY SPTBN2 PSMB6 EDC4 ITPR3 EFTUD2 SUPT5H ZNF638 ZC3H7B CACNA1B FLNA FLNB FLNC RANGAP1 COPA RTTN OBSL1 CCT2 LMNB2 PDIA6 NUP155 ATAD3A MACF1 PROSER2 DNAAF1 | 7.50e-05 | 902 | 239 | 25 | int:OBSL1 |
| Interaction | RHOQ interactions | DOCK11 SPTBN2 C2CD5 FAT1 RRAGD FLRT2 GNAS IGSF3 RRAS2 SLC4A7 MICALL1 STEAP3 DAAM1 PEAK1 PCDH7 EPHA7 | 8.16e-05 | 442 | 239 | 16 | int:RHOQ |
| Interaction | B4GALT2 interactions | 8.81e-05 | 119 | 239 | 8 | int:B4GALT2 | |
| Interaction | LLCFC1 interactions | 9.90e-05 | 121 | 239 | 8 | int:LLCFC1 | |
| Interaction | ENO1 interactions | DDAH2 INPPL1 ITGA4 RYR3 EFTUD2 STK10 SUPT5H RECQL4 ZNF638 NHS COL14A1 DNAH8 FLNC FAT4 RANGAP1 VPS26B GLIS3 OBSL1 GIPC3 PCDH7 XPO7 | 9.95e-05 | 701 | 239 | 21 | int:ENO1 |
| Interaction | DTX4 interactions | 1.19e-04 | 22 | 239 | 4 | int:DTX4 | |
| Interaction | NUP210P1 interactions | 1.34e-04 | 42 | 239 | 5 | int:NUP210P1 | |
| Interaction | AFDN interactions | ITGA4 ZNF638 RRAS2 SLC4A7 DSCAM OBSL1 ABLIM3 MACF1 TNK2 CGNL1 PEAK1 PCDH7 EPHA7 | 1.83e-04 | 333 | 239 | 13 | int:AFDN |
| Interaction | CUL7 interactions | LRWD1 IMPDH2 ACLY ZKSCAN8 EFTUD2 SUPT5H ZNF638 BAG6 NSUN5P1 FLNA FLNB RANGAP1 COPA CAMK4 OBSL1 CCT2 LMNB2 MSH6 PDIA6 NUP155 ATAD3A MACF1 EPHA7 | 1.91e-04 | 845 | 239 | 23 | int:CUL7 |
| Interaction | PLEC interactions | ITGA4 STAT6 ITPR1 EFTUD2 RECQL4 PLCD1 FLNA DSCAM OBSL1 WDFY4 TBCK MACF1 PRKCH PCDH7 SMAD9 | 2.03e-04 | 430 | 239 | 15 | int:PLEC |
| Interaction | MTNR1B interactions | 2.12e-04 | 135 | 239 | 8 | int:MTNR1B | |
| Interaction | RHOG interactions | PCNX3 SPTBN2 COQ8B C2CD5 ITPR1 ITPR3 FAT1 RRAGD AFG3L2 FLRT2 GNAS TIMM44 IGSF3 RRAS2 SLC4A7 LMNB2 MICALL1 NUP155 ATAD3A STEAP3 MACF1 DAAM1 PEAK1 EPHA7 | 2.21e-04 | 910 | 239 | 24 | int:RHOG |
| Interaction | RHOC interactions | SPTBN2 ITPR1 STK10 FAT1 AFG3L2 FLRT2 GNAS RRAS2 FAT4 SLC4A7 LMNB2 NUP155 STEAP3 MACF1 DAAM1 PEAK1 PCDH7 EPHA7 | 2.23e-04 | 584 | 239 | 18 | int:RHOC |
| Interaction | FCER2 interactions | 2.53e-04 | 11 | 239 | 3 | int:FCER2 | |
| GeneFamily | Cadherin related | 1.45e-05 | 17 | 165 | 4 | 24 | |
| GeneFamily | Fibronectin type III domain containing | 1.64e-05 | 160 | 165 | 9 | 555 | |
| GeneFamily | WD repeat domain containing | LRWD1 WDR25 WDFY2 UTP15 HERC1 TAF5 NWD1 COPA WDR88 WDFY4 CFAP52 | 2.95e-05 | 262 | 165 | 11 | 362 |
| GeneFamily | Non-clustered protocadherins | 1.55e-04 | 12 | 165 | 3 | 21 | |
| GeneFamily | EF-hand domain containing | 1.86e-04 | 219 | 165 | 9 | 863 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 2.47e-04 | 3 | 165 | 2 | 297 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.47e-04 | 3 | 165 | 2 | 287 | |
| GeneFamily | SH2 domain containing | 3.27e-04 | 101 | 165 | 6 | 741 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.98e-04 | 161 | 165 | 7 | 593 | |
| GeneFamily | Phosphatidylinositol transfer proteins | 1.21e-03 | 6 | 165 | 2 | 1151 | |
| GeneFamily | AAA ATPases | 1.38e-03 | 53 | 165 | 4 | 413 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 2.24e-03 | 8 | 165 | 2 | 658 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 2.29e-03 | 29 | 165 | 3 | 396 | |
| GeneFamily | Glycosyl transferases group 1 domain containing | 3.55e-03 | 10 | 165 | 2 | 427 | |
| GeneFamily | Low density lipoprotein receptors | 6.04e-03 | 13 | 165 | 2 | 634 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | SPTBN2 PEX1 ITPKB ITPR1 ITPR3 IGSF3 FLNA FLNC OBSL1 MSH6 GTF2I CELSR2 LRP5 PCDH7 | 2.77e-07 | 276 | 239 | 14 | M3063 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | IGFN1 PEX1 CSMD2 RYR2 C2CD5 NRP2 ERAP2 SCN9A PCDH11X GPC2 HERC1 IGSF3 SLC4A8 DSCAM COL6A6 ARID4A KSR2 MUC19 ARFGEF1 PCDHA7 ABLIM3 FRY AKAP9 TNK2 PNCK DAAM1 UBASH3B PCDH7 | 1.13e-06 | 1106 | 239 | 28 | M39071 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | ELAPOR2 ATP8B4 ABL1 ACLY PSMB6 NCAPG2 ITPKB NRP2 ITPR1 FAT1 HPCAL1 XRN1 PLCG1 FLRT2 GNAS SETD3 COPA RRM2B OBSL1 CHSY1 MSH6 TENM3 SETBP1 CGNL1 DAAM1 XPO7 | 2.04e-06 | 1009 | 239 | 26 | M157 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | C2CD5 ITPR1 STK10 TLK1 FAT1 HPCAL1 ZNF638 FLRT2 DENND5A SETD3 FLNB RRAS2 SLC4A7 ARID4A KAT6A ARFGEF1 CHSY1 CBFB ABLIM3 MSH6 AKAP9 MACF1 DAAM1 | 4.15e-06 | 856 | 239 | 23 | M4500 |
| Coexpression | GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP | 4.88e-06 | 137 | 239 | 9 | M6346 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN | 1.33e-05 | 155 | 239 | 9 | M6675 | |
| Coexpression | GSE3982_MAC_VS_TH1_DN | ATP8B4 NCAPG2 POLR3D ERAP2 TAF5 CHSY1 TFDP2 PITPNM1 NUP155 PPP6R2 | 1.56e-05 | 199 | 239 | 10 | M5511 |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 2.29e-05 | 166 | 239 | 9 | M39026 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | ACLY STAT5B DHRS4 DENND5A DNAH8 FLNA CAMK4 DHRS4L2 TACC2 LMNB2 CUBN ATAD3B AKAP9 ATAD3A DDX3Y EPHA7 | 2.57e-05 | 520 | 239 | 16 | MM1008 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CSMD2 RYR2 ERAP2 SCN9A CACNA1B DSCAM ARID4A KSR2 MUC19 PCDHA7 ABLIM3 WDFY4 FRY AKAP9 TNK2 PNCK DAAM1 UBASH3B PCDH7 | 2.71e-05 | 703 | 239 | 19 | M39070 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | DDAH2 ITGA4 STAT5A ITPKB ITPR3 ESRP2 TRIL ATP6V1C2 GNAS FAM181B ALOX12 RRAS2 FAT4 HTR2C GLIS3 HTRA4 CBFB ABLIM3 GIPC3 CNNM1 HMCN1 LRP5 PRKCH CGNL1 | 5.19e-05 | 1074 | 239 | 24 | M1941 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | INPPL1 CSMD2 ITPKB TRIL FAT1 FAM181B FAT3 WNT7B GLIS3 OBSL1 TNK2 PEAK1 DNAAF1 CRB2 | 5.64e-05 | 439 | 239 | 14 | M39054 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | C2CD5 STAT5B STK10 TLK1 CC2D2A PLCG1 DENND5A RRAS2 IFT57 CAMK4 BTBD10 SAMHD1 MACF1 PRKCH UBASH3B | 5.85e-05 | 498 | 239 | 15 | M1741 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | PPRC1 ZNF638 GPC2 DENND5A ZC3H7B NSUN5P1 RANGAP1 MICALL1 ATAD3B ATAD3A TNK2 PPP6R2 | 7.01e-05 | 338 | 239 | 12 | M17094 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | C2CD5 STAT5B STK10 TLK1 CC2D2A PLCG1 DENND5A RRAS2 IFT57 CAMK4 BTBD10 SAMHD1 MACF1 PRKCH UBASH3B | 7.15e-05 | 507 | 239 | 15 | MM1030 |
| Coexpression | GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP | 7.43e-05 | 193 | 239 | 9 | M3549 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ABL1 IMPDH2 PEX1 ITPR1 CSRNP1 PITPNM2 AVEN FLNB SLC4A8 APOA5 TTC27 PRKCH PEAK1 UBASH3B PCDH7 SMAD9 | 8.27e-05 | 574 | 239 | 16 | M8215 |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN | 9.76e-05 | 200 | 239 | 9 | M9641 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP | 9.76e-05 | 200 | 239 | 9 | M3970 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN | 9.76e-05 | 200 | 239 | 9 | M7426 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP | 9.76e-05 | 200 | 239 | 9 | M5049 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 9.76e-05 | 200 | 239 | 9 | M7776 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL | NCALD FYCO1 STK10 FCGBP RRAGD ERAP2 PTRH1 DENND5A DHRS4L2 RTTN GLIS3 TACC2 SAMHD1 CBFB MICALL1 CLDND2 PRKCH PROSER2 EDEM1 | 9.90e-05 | 775 | 239 | 19 | M45713 |
| Coexpression | PEREZ_TP53_TARGETS | FYCO1 WDFY2 ITPKB ESRP2 CFLAR COL21A1 IQSEC1 FLRT2 GNAS TAF5 FLNC WNT7B ARFGEF2 CAMK1 S1PR5 FRY PAXBP1 AKAP9 CELSR2 LRP5 PROSER2 CGNL1 EDEM1 MUC5AC SMAD9 | 1.11e-04 | 1201 | 239 | 25 | M4391 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ABL1 IMPDH2 PEX1 ITPR1 CSRNP1 PITPNM2 AVEN FLNB SLC4A8 APOA5 TTC27 PRKCH PEAK1 UBASH3B PCDH7 SMAD9 | 1.38e-04 | 600 | 239 | 16 | MM1025 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.49e-04 | 166 | 239 | 8 | M6826 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP | 1.55e-04 | 12 | 239 | 3 | M1748 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP | 1.55e-04 | 12 | 239 | 3 | MM732 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 1.62e-04 | 168 | 239 | 8 | M6874 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | WDFY2 CSRNP1 FLRT2 SLC4A7 BTBD10 SAMHD1 MACF1 PNCK PEAK1 UBASH3B | 1.72e-04 | 265 | 239 | 10 | M1684 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.act.Sp, TCRd+ Vg2- CD44+, Spleen, avg-3 | ITGA4 ITGAX ITPKB ITPR3 ZNRF3 PLCG1 PITPNM2 RRAS2 CAMK4 CHSY1 CLDND2 SETBP1 MACF1 TNK2 PRKCH PEAK1 | 4.85e-06 | 377 | 234 | 16 | GSM476681_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | NCALD ATP8B4 ITGA4 ITGAX XRN1 PLCG1 SLC4A7 CAMK4 CHSY1 S1PR5 CLDND2 MACF1 PRKCH PEAK1 UBASH3B | 2.79e-05 | 387 | 234 | 15 | GSM538392_500 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DENND2A FREM1 RYR2 COL21A1 NHS COL14A1 FAT4 COL6A6 FAT3 ABLIM3 HMCN1 TENM3 SETBP1 PCDH7 | 4.67e-12 | 198 | 241 | 14 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | NCALD RYR2 RYR3 ITPR1 COL21A1 NHS COL14A1 FLNA FLNB FAT3 FRY MACF1 PCDH7 | 3.63e-11 | 188 | 241 | 13 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | DENND2A FREM1 RYR2 COL21A1 COL14A1 FAT4 COL6A6 FAT3 ABLIM3 HMCN1 TENM3 SETBP1 PCDH7 | 7.40e-11 | 199 | 241 | 13 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 FREM1 RYR2 RYR3 FAT1 SCN9A PCDH11X FAT4 FAT3 PKHD1L1 HMCN1 EPHA7 | 4.10e-10 | 184 | 241 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 FREM1 RYR2 RYR3 FAT1 SCN9A PCDH11X FAT4 FAT3 PKHD1L1 HMCN1 EPHA7 | 4.10e-10 | 184 | 241 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 FREM1 RYR2 RYR3 FAT1 SCN9A PCDH11X FAT4 FAT3 PKHD1L1 HMCN1 EPHA7 | 4.10e-10 | 184 | 241 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 RYR2 COL21A1 NHS COL14A1 COL6A6 FAT3 GLIS3 TENM3 SETBP1 PCDH7 | 6.30e-10 | 191 | 241 | 12 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A FREM1 RYR2 COL21A1 FAT4 COL6A6 FAT3 HMCN1 TENM3 SETBP1 MACF1 PCDH7 | 6.30e-10 | 191 | 241 | 12 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 COL21A1 NHS COL14A1 COL6A6 FAT3 GLIS3 ABLIM3 TENM3 SETBP1 PCDH7 | 7.10e-10 | 193 | 241 | 12 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A FREM1 RYR2 COL21A1 COL14A1 FLRT2 COL6A6 FAT3 HMCN1 TENM3 SETBP1 PCDH7 | 1.07e-09 | 200 | 241 | 12 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A FREM1 RYR2 COL21A1 COL14A1 FLRT2 COL6A6 FAT3 HMCN1 TENM3 SETBP1 PCDH7 | 1.07e-09 | 200 | 241 | 12 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A FREM1 RYR2 COL21A1 COL14A1 FLRT2 COL6A6 FAT3 HMCN1 TENM3 SETBP1 PCDH7 | 1.07e-09 | 200 | 241 | 12 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.35e-09 | 189 | 241 | 11 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | PCDH11X FLRT2 FLNB CHSY1 PKHD1L1 HMCN1 SETBP1 PRKCH CGNL1 PCDH7 SMAD9 | 8.66e-09 | 192 | 241 | 11 | c0c34785a7bdf461722029b322e9184e3d9b3c26 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 RYR2 COL21A1 COL14A1 COL6A6 FAT3 GLIS3 TENM3 SETBP1 PCDH7 | 8.66e-09 | 192 | 241 | 11 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | DENND2A FREM1 RYR2 COL21A1 COL6A6 FAT3 HMCN1 TENM3 SETBP1 MACF1 PCDH7 | 8.66e-09 | 192 | 241 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 RYR2 COL21A1 NHS COL14A1 COL6A6 FAT3 GLIS3 TENM3 PCDH7 | 8.66e-09 | 192 | 241 | 11 | deeecd26972241846b4cb998edf0c7a87ff0c4df |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | DENND2A FREM1 RYR2 COL21A1 FAT4 COL6A6 FAT3 ABLIM3 HMCN1 SETBP1 PCDH7 | 9.14e-09 | 193 | 241 | 11 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.19e-09 | 149 | 241 | 10 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ATP8B4 DOCK11 ITGA4 ITGAX STK10 IQSEC1 CAMK4 SAMHD1 WDFY4 CSF2RA PRKCH | 1.13e-08 | 197 | 241 | 11 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A FREM1 RYR2 COL21A1 COL6A6 FAT3 SAMHD1 HMCN1 TENM3 SETBP1 PCDH7 | 1.32e-08 | 200 | 241 | 11 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | NCALD TNMD TRIL COL21A1 COL14A1 FLRT2 FLNC FAT4 COL6A6 PCDH7 EPHA7 | 1.32e-08 | 200 | 241 | 11 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A FREM1 RYR2 COL21A1 COL6A6 FAT3 ABLIM3 HMCN1 TENM3 SETBP1 PCDH7 | 1.32e-08 | 200 | 241 | 11 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A FREM1 RYR2 COL14A1 FLRT2 FAT4 COL6A6 FAT3 HMCN1 TENM3 SETBP1 | 1.32e-08 | 200 | 241 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | DOCK11 FAT1 ZNRF3 FAT3 WNT7B CNNM1 PROSER2 UBASH3B SMAD9 EPHA7 | 6.49e-08 | 183 | 241 | 10 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | DENND2A RYR2 COL21A1 COL6A6 FAT3 SAMHD1 HMCN1 TENM3 SETBP1 MACF1 | 7.95e-08 | 187 | 241 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 RYR2 NHS COL14A1 COL6A6 FAT3 GLIS3 SETBP1 PCDH7 | 8.78e-08 | 189 | 241 | 10 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | DENND2A FREM1 RYR2 COL21A1 COL6A6 FAT3 HMCN1 TENM3 SETBP1 PCDH7 | 9.23e-08 | 190 | 241 | 10 | 3a42a9b98d954685d38a741f44545898d0e3e9ce |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.02e-07 | 192 | 241 | 10 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 NHS COL14A1 COL6A6 FAT3 GLIS3 TENM3 SETBP1 PCDH7 | 1.12e-07 | 194 | 241 | 10 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DENND2A FREM1 RYR2 COL21A1 FAT4 FAT3 GLIS3 ABLIM3 HMCN1 PCDH7 | 1.12e-07 | 194 | 241 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | PCDH11X FLNB PCDH11Y CHSY1 PKHD1L1 HMCN1 SETBP1 PRKCH CGNL1 SMAD9 | 1.12e-07 | 194 | 241 | 10 | b6cc849fa08599bff9839ef382d190cc964e273e |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A FREM1 COL21A1 NHS COL14A1 COL6A6 FAT3 GLIS3 TENM3 PCDH7 | 1.12e-07 | 194 | 241 | 10 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | DENND2A FREM1 RYR2 COL21A1 COL14A1 COL6A6 FAT3 HMCN1 SETBP1 PCDH7 | 1.23e-07 | 196 | 241 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.36e-07 | 198 | 241 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.36e-07 | 198 | 241 | 10 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DENND2A RYR2 NRP2 COL21A1 PITPNM2 FLNA FLNC PNCK PCDH7 EPHA7 | 1.36e-07 | 198 | 241 | 10 | 22e766df1276c5b14aa0d83f434f47140ebb98ea |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-07 | 160 | 241 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-07 | 160 | 241 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.10e-07 | 171 | 241 | 9 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.74e-07 | 174 | 241 | 9 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.22e-07 | 176 | 241 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.74e-07 | 178 | 241 | 9 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 5.74e-07 | 178 | 241 | 9 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-07 | 179 | 241 | 9 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.60e-07 | 181 | 241 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.57e-07 | 184 | 241 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 7.57e-07 | 184 | 241 | 9 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.57e-07 | 184 | 241 | 9 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.92e-07 | 185 | 241 | 9 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-07 | 186 | 241 | 9 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 8.67e-07 | 187 | 241 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.47e-07 | 189 | 241 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 9.47e-07 | 189 | 241 | 9 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-07 | 189 | 241 | 9 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.47e-07 | 189 | 241 | 9 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-07 | 190 | 241 | 9 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.90e-07 | 190 | 241 | 9 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-07 | 190 | 241 | 9 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.90e-07 | 190 | 241 | 9 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 191 | 241 | 9 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.03e-06 | 191 | 241 | 9 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 192 | 241 | 9 | 14a816ef116aa992f86edab411f043cf7d07fe04 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-06 | 192 | 241 | 9 | 847822514d747a21d5eb40e04ba9a023fd32bd65 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 192 | 241 | 9 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 192 | 241 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 192 | 241 | 9 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-06 | 192 | 241 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 192 | 241 | 9 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-06 | 192 | 241 | 9 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.13e-06 | 193 | 241 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.13e-06 | 193 | 241 | 9 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-06 | 193 | 241 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.13e-06 | 193 | 241 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.13e-06 | 193 | 241 | 9 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-06 | 194 | 241 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.18e-06 | 194 | 241 | 9 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-06 | 195 | 241 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.23e-06 | 195 | 241 | 9 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.28e-06 | 196 | 241 | 9 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-06 | 196 | 241 | 9 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-06 | 196 | 241 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.34e-06 | 197 | 241 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 197 | 241 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.34e-06 | 197 | 241 | 9 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | DOCK11 ITGAX STK10 IQSEC1 DENND5A SAMHD1 WDFY4 CSF2RA UBASH3B | 1.39e-06 | 198 | 241 | 9 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.39e-06 | 198 | 241 | 9 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 1.39e-06 | 198 | 241 | 9 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.39e-06 | 198 | 241 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 198 | 241 | 9 | cbb63b255bdc92a557c5db1f08f7766ed9346607 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.39e-06 | 198 | 241 | 9 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-06 | 198 | 241 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.51e-06 | 200 | 241 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-06 | 200 | 241 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.51e-06 | 200 | 241 | 9 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.51e-06 | 200 | 241 | 9 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.51e-06 | 200 | 241 | 9 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.51e-06 | 200 | 241 | 9 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.51e-06 | 200 | 241 | 9 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.51e-06 | 200 | 241 | 9 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 3.91e-07 | 7 | 237 | 4 | CID009547999 | |
| Drug | Br2BAPTA | 3.91e-07 | 7 | 237 | 4 | CID003081001 | |
| Drug | R 478 | 3.57e-06 | 11 | 237 | 4 | CID000084223 | |
| Drug | 8-amino-cADPR | 3.57e-06 | 11 | 237 | 4 | CID003081323 | |
| Drug | fura 2 | 5.05e-06 | 65 | 237 | 7 | CID000057054 | |
| Drug | strontium | 6.85e-06 | 68 | 237 | 7 | CID000104798 | |
| Drug | panobinostat | DENND2A NCALD ABL1 FREM1 RYR3 STAT6 NRP2 ESRP2 CFLAR RRAGD COL21A1 CC2D2A COL14A1 FLRT2 GNAS FLNB PNMT FAT3 KAT6A GLIS3 L1TD1 CHSY1 CR2 MICALL1 S1PR5 CSF2RA STEAP3 PRKCH CGNL1 PCDH7 ELP4 EPHA7 | 9.10e-06 | 1333 | 237 | 32 | ctd:C496932 |
| Drug | Methamphetamine | ZNF142 NCALD ABL1 PCNX3 INPPL1 EDC4 STAT6 FCGBP SUPT5H XRN1 ZNF638 PLCD1 ATP6V1C2 DENND5A CLUH ALG1 FLNA FLNB FLNC HTR2C KAT6A OBSL1 CCT2 TACC2 CUBN KLHDC9 ABCC6 GIPC3 MICALL1 MACF1 PPP6R2 SERPINA5 MYBPC3 | 9.62e-06 | 1401 | 237 | 33 | ctd:D008694 |
| Drug | Gvapspat amide | 1.43e-05 | 15 | 237 | 4 | CID000125015 | |
| Drug | CNS 1145 | 2.19e-05 | 33 | 237 | 5 | CID000190902 | |
| Drug | IHC-64 | 2.19e-05 | 33 | 237 | 5 | CID000162753 | |
| Drug | AC1NBU2S | 3.15e-05 | 117 | 237 | 8 | CID004473765 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.20e-05 | 190 | 237 | 10 | 7145_DN | |
| Drug | procaine | 3.35e-05 | 153 | 237 | 9 | CID000004914 | |
| Drug | AC1L1GTT | RYR2 RYR3 ITPR1 ITPR3 CFLAR PTRH1 CACNA1B FLNA CAMK4 CAMK1 PRKCH | 3.53e-05 | 233 | 237 | 11 | CID000003837 |
| Drug | IAA-94 | 4.11e-05 | 61 | 237 | 6 | CID000003667 | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A | RYR2 ITPKB CFLAR COL14A1 PLCG1 SMG6 SLC4A7 DSCAM CAMK1 PCDH7 | 4.35e-05 | 197 | 237 | 10 | 4717_DN |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | STAT5B PLCG1 ZC3H7B SIN3B DSCAM KAT6A ABLIM3 MICALL1 DNAAF1 PPP6R2 | 4.35e-05 | 197 | 237 | 10 | 7440_DN |
| Drug | Naloxone hydrochloride [357-08-4]; Up 200; 11uM; PC3; HG-U133A | DENND2A PECR NRP2 CFLAR PLCD1 ARFGEF1 SAMHD1 TFDP2 MICALL1 TNK2 | 4.54e-05 | 198 | 237 | 10 | 1924_UP |
| Drug | abrine | ITGA4 ITGAX CFLAR FCGBP PCDH11X DNAH8 FLNA HTR2C HTRA4 CBFB CR2 DNAAF1 | 4.78e-05 | 285 | 237 | 12 | ctd:C496492 |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | PECR ACADS ACLY ITPR1 ITPR3 CFLAR POLR3D ZC3H7B ARFGEF2 GTF2I | 4.95e-05 | 200 | 237 | 10 | 6356_DN |
| Drug | pimozide | 5.67e-05 | 127 | 237 | 8 | CID000016362 | |
| Drug | AC1L1CR9 | 5.96e-05 | 21 | 237 | 4 | CID000002023 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 4.86e-07 | 3 | 233 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 4.86e-07 | 3 | 233 | 3 | C1842563 | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 4.86e-07 | 3 | 233 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | SPTBN2 FAT1 PCDH11X GNAS DNAH8 FLNC ARFGEF1 LMNB2 CUBN ABCC6 MSH6 AKAP9 RHPN2 SETBP1 DCHS1 SMAD9 EPHA7 | 4.80e-05 | 702 | 233 | 17 | C0009402 |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 6.21e-05 | 2 | 233 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 6.21e-05 | 2 | 233 | 2 | cv:C1832390 | |
| Disease | Heterotopic Ossification | 6.21e-05 | 2 | 233 | 2 | C0029396 | |
| Disease | Periventricular gray matter heterotopia | 6.21e-05 | 2 | 233 | 2 | C1849173 | |
| Disease | Periventricular nodular heterotopia | 6.21e-05 | 2 | 233 | 2 | cv:C1868720 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.66e-04 | 14 | 233 | 3 | DOID:898 (implicated_via_orthology) | |
| Disease | Nasal Type Extranodal NK/T-Cell Lymphoma | 1.85e-04 | 3 | 233 | 2 | C0392788 | |
| Disease | congenital disorder of glycosylation Ik (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:0080563 (implicated_via_orthology) | |
| Disease | Lymphoma, Extranodal NK-T-Cell | 1.85e-04 | 3 | 233 | 2 | C1955906 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.85e-04 | 3 | 233 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | cortical thickness | SPTBN2 NRP2 COL21A1 SETD3 CLUH SMG6 PITPNM2 FLNB PTBP2 FAT3 ESPNL GLIS3 ARFGEF2 CHSY1 TACC2 TFDP2 MICALL1 MACF1 PCDH7 CRB2 EPHA7 | 2.19e-04 | 1113 | 233 | 21 | EFO_0004840 |
| Disease | susceptibility to mononucleosis measurement | 2.19e-04 | 69 | 233 | 5 | EFO_0008403 | |
| Disease | Seizures | 3.60e-04 | 218 | 233 | 8 | C0036572 | |
| Disease | neuromuscular disease (implicated_via_orthology) | 3.69e-04 | 4 | 233 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | ACADS PCNX3 DOCK11 BCAT2 WDFY2 RYR2 ITPR1 TRIL HPCAL1 PLCG1 SLC4A8 GLIS3 SLCO1B7 CELSR2 RHPN2 CGNL1 UBASH3B PPP6R2 | 3.76e-04 | 914 | 233 | 18 | EFO_0004532 |
| Disease | myopathy (implicated_via_orthology) | 5.61e-04 | 48 | 233 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Metabolic Syndrome X | 5.82e-04 | 21 | 233 | 3 | C0524620 | |
| Disease | Polycystic Kidney - body part | 6.11e-04 | 5 | 233 | 2 | C1567435 | |
| Disease | heart failure | 6.99e-04 | 185 | 233 | 7 | EFO_0003144 | |
| Disease | Acidosis, Lactic | 9.12e-04 | 6 | 233 | 2 | C0001125 | |
| Disease | glucagon measurement, glucose tolerance test | 9.12e-04 | 6 | 233 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 9.12e-04 | 6 | 233 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | congenital disorder of glycosylation (implicated_via_orthology) | 9.12e-04 | 6 | 233 | 2 | DOID:5212 (implicated_via_orthology) | |
| Disease | Intellectual Disability | PECR ZNF142 IQSEC1 GNAS CACNA1B RRM2B TTI2 RTTN FRY SETBP1 MACF1 | 9.19e-04 | 447 | 233 | 11 | C3714756 |
| Disease | Adenocarcinoma of large intestine | 1.00e-03 | 96 | 233 | 5 | C1319315 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.11e-03 | 26 | 233 | 3 | DOID:234 (is_implicated_in) | |
| Disease | Periventricular Nodular Heterotopia | 1.27e-03 | 7 | 233 | 2 | C1868720 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.38e-03 | 28 | 233 | 3 | DOID:3717 (is_marker_for) | |
| Disease | Meckel syndrome (implicated_via_orthology) | 1.68e-03 | 8 | 233 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | Epileptic encephalopathy | 1.69e-03 | 30 | 233 | 3 | C0543888 | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.86e-03 | 31 | 233 | 3 | DOID:9452 (implicated_via_orthology) | |
| Disease | alpha-1-antitrypsin measurement | 2.15e-03 | 9 | 233 | 2 | EFO_0008327 | |
| Disease | mitral valve prolapse (is_implicated_in) | 2.15e-03 | 9 | 233 | 2 | DOID:988 (is_implicated_in) | |
| Disease | internet addiction disorder | 2.23e-03 | 33 | 233 | 3 | EFO_0803368 | |
| Disease | aspartate aminotransferase measurement | FYCO1 ITPR1 ERAP2 ZNF638 SMG6 NSUN5P1 FLNB SLC4A7 APOA5 DNAH2 MUC19 PDPK2P CUBN CNNM1 UBASH3B MYBPC3 | 2.35e-03 | 904 | 233 | 16 | EFO_0004736 |
| Disease | Meckel-Gruber syndrome | 2.68e-03 | 10 | 233 | 2 | cv:C0265215 | |
| Disease | hypertension (is_implicated_in) | 2.78e-03 | 121 | 233 | 5 | DOID:10763 (is_implicated_in) | |
| Disease | platelet component distribution width | DENND2A C2CD5 TLK1 HPCAL1 GNAS HERC1 SLC4A7 APOA5 MPDU1 RTTN CUBN MICALL1 MACF1 XPO7 | 2.88e-03 | 755 | 233 | 14 | EFO_0007984 |
| Disease | breast carcinoma | PPRC1 SPTBN2 ITPR1 CFLAR TRIL ZNRF3 COL14A1 ZC3H7B SMG6 SLC4A7 ZNF577 WNT7B TACC2 LMNB2 GTF2I AKAP9 SETBP1 | 3.18e-03 | 1019 | 233 | 17 | EFO_0000305 |
| Disease | meningitis | 3.26e-03 | 11 | 233 | 2 | MONDO_0021108 | |
| Disease | motor function measurement | 3.26e-03 | 11 | 233 | 2 | EFO_0010749 | |
| Disease | Cocaine Abuse | 3.43e-03 | 127 | 233 | 5 | C0009171 | |
| Disease | uric acid measurement | PCNX3 RRAGD GNAS NSUN5P1 FAT4 DSCAM FAT3 TTC27 CUBN TFDP2 SETBP1 UBASH3B | 3.54e-03 | 610 | 233 | 12 | EFO_0004761 |
| Disease | small cell lung carcinoma | 3.75e-03 | 80 | 233 | 4 | EFO_0000702 | |
| Disease | ciliopathy (implicated_via_orthology) | 3.87e-03 | 40 | 233 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 3.87e-03 | 40 | 233 | 3 | C0598589 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.89e-03 | 12 | 233 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | aortic measurement | 3.95e-03 | 251 | 233 | 7 | EFO_0020865 | |
| Disease | macula measurement | 4.01e-03 | 189 | 233 | 6 | EFO_0008375 | |
| Disease | Combined immunodeficiency | 4.15e-03 | 41 | 233 | 3 | C0494261 | |
| Disease | calcium measurement | ITPKB ITPR1 HPCAL1 GNAS PITPNM2 BTBD10 DNAH2 ABCC6 CELSR2 MACF1 CGNL1 UBASH3B | 4.46e-03 | 628 | 233 | 12 | EFO_0004838 |
| Disease | salicylurate measurement | 4.57e-03 | 13 | 233 | 2 | EFO_0010532 | |
| Disease | Congenital Hypothyroidism | 4.57e-03 | 13 | 233 | 2 | C0010308 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 4.75e-03 | 43 | 233 | 3 | EFO_0022254 | |
| Disease | Profound Mental Retardation | 5.02e-03 | 139 | 233 | 5 | C0020796 | |
| Disease | Mental deficiency | 5.02e-03 | 139 | 233 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 5.02e-03 | 139 | 233 | 5 | C0025363 | |
| Disease | cholesteryl ester 20:5 measurement | 5.07e-03 | 44 | 233 | 3 | EFO_0010349 | |
| Disease | receptive language perception, parental genotype effect measurement | 5.31e-03 | 14 | 233 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | obesity (is_implicated_in) | 5.92e-03 | 91 | 233 | 4 | DOID:9970 (is_implicated_in) | |
| Disease | Obesity | 5.93e-03 | 205 | 233 | 6 | C0028754 | |
| Disease | Adenocarcinoma of lung (disorder) | 6.06e-03 | 206 | 233 | 6 | C0152013 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 6.09e-03 | 15 | 233 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | N-acetylmethionine measurement | 6.09e-03 | 15 | 233 | 2 | EFO_0021427 | |
| Disease | anemia (implicated_via_orthology) | 6.09e-03 | 15 | 233 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Meckel-Gruber syndrome | 6.09e-03 | 15 | 233 | 2 | C0265215 | |
| Disease | congenital disorder of glycosylation type I (implicated_via_orthology) | 6.09e-03 | 15 | 233 | 2 | DOID:0050570 (implicated_via_orthology) | |
| Disease | Proteinuria | 6.09e-03 | 15 | 233 | 2 | HP_0000093 | |
| Disease | glycerate measurement | 6.09e-03 | 15 | 233 | 2 | EFO_0021029 | |
| Disease | infant head circumference | 6.09e-03 | 15 | 233 | 2 | EFO_0004577 | |
| Disease | Hypertriglyceridemia | 6.09e-03 | 15 | 233 | 2 | C0020557 | |
| Disease | Neuralgia, Supraorbital | 6.93e-03 | 16 | 233 | 2 | C0038870 | |
| Disease | Paroxysmal Nerve Pain | 6.93e-03 | 16 | 233 | 2 | C0751373 | |
| Disease | Nerve Pain | 6.93e-03 | 16 | 233 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 6.93e-03 | 16 | 233 | 2 | C0751371 | |
| Disease | Congenital total cataract | 6.93e-03 | 16 | 233 | 2 | C0266539 | |
| Disease | Neuralgia | 6.93e-03 | 16 | 233 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 6.93e-03 | 16 | 233 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 6.93e-03 | 16 | 233 | 2 | C0234249 | |
| Disease | infant expressive language ability | 6.93e-03 | 16 | 233 | 2 | EFO_0006316 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 6.93e-03 | 16 | 233 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 6.93e-03 | 16 | 233 | 2 | C0423711 | |
| Disease | Diarrhea | 6.93e-03 | 16 | 233 | 2 | HP_0002014 | |
| Disease | Neuralgia, Vidian | 6.93e-03 | 16 | 233 | 2 | C0042656 | |
| Disease | alkaline phosphatase measurement | BCAT2 GCK ITPKB ITPR1 TLK1 ZNRF3 RECQL4 CLUH SLC4A8 MPDU1 RHPN2 MACF1 UBASH3B EDEM1 PPP6R2 MYBPC3 | 7.07e-03 | 1015 | 233 | 16 | EFO_0004533 |
| Disease | Inhalant adrenergic use measurement | 7.14e-03 | 96 | 233 | 4 | EFO_0009941 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.28e-03 | 152 | 233 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | mean platelet volume | ATP8B4 PCNX3 DOCK11 TLK1 GNAS ALOX12 PITPNM2 COL6A6 ARID4A RTTN NARF FRY SETBP1 PROSER2 UBASH3B MYBPC3 | 7.39e-03 | 1020 | 233 | 16 | EFO_0004584 |
| Disease | glutamine measurement | 7.40e-03 | 97 | 233 | 4 | EFO_0009768 | |
| Disease | cholesterol to total lipids in small HDL percentage | 7.66e-03 | 51 | 233 | 3 | EFO_0022240 | |
| Disease | Van Buchem disease | 7.81e-03 | 17 | 233 | 2 | C0432272 | |
| Disease | Moyamoya Disease | 7.81e-03 | 17 | 233 | 2 | C0026654 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 7.81e-03 | 17 | 233 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 7.81e-03 | 17 | 233 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 7.81e-03 | 17 | 233 | 2 | C0751778 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVARAAELFGLTAEE | 101 | Q86Y79 | |
| RALTSRGNELESIAF | 1326 | Q86US8 | |
| ESIAFRSEDITGQLG | 1336 | Q86US8 | |
| RDFITGEVISALGRT | 86 | O94929 | |
| VAEGIGSTVFRAILD | 216 | Q9BSF8 | |
| EEGTELSQRLVRSGF | 1816 | Q99996 | |
| RTELTALGTTDAVGL | 3046 | Q99996 | |
| TFGLGLTSEEQEVRR | 166 | Q4VNC0 | |
| ERSAFTERDAGSGLV | 256 | Q9BT22 | |
| RVGAIVETRTSDGSF | 61 | P29374 | |
| RLGSDFSVGAIVRFE | 1746 | Q7Z408 | |
| LGIRGSSTANLIFED | 231 | P16219 | |
| LGARAGSSESIAAFI | 716 | P46379 | |
| EIFFGRITTGAQDDL | 636 | Q9Y4W6 | |
| AFTERDSGSGLVTRL | 56 | C9J202 | |
| DRIFTGSTRLDGNAI | 1126 | Q9Y6D6 | |
| GSTRLDGNAIVDFVR | 1131 | Q9Y6D6 | |
| LESIRTAGTLFGEGF | 271 | Q9NVI7 | |
| IVGEVFASDRDLGTD | 3316 | Q6V0I7 | |
| AGLLTEEIRSRAVGF | 991 | A8K2U0 | |
| AAIVTDIFNTSDGGR | 31 | P28335 | |
| AVDRIFTGSTRLDGN | 1071 | Q9Y6D5 | |
| DQLREELSRAFAGTG | 251 | Q6Q788 | |
| ELSRAFAGTGTEEGA | 256 | Q6Q788 | |
| TLRLRSGGAATVEEA | 221 | Q8TF64 | |
| DAGTRGRLESAQATF | 251 | P53365 | |
| VTSELGADISRLAGF | 181 | Q8TF62 | |
| DGDFIVESTSGIVRT | 861 | Q9HCU4 | |
| LVTASTDGIGFAIAR | 36 | Q9BTZ2 | |
| TGILATAGTDFDLRT | 176 | Q00975 | |
| GNETELLRDTFTSLG | 261 | O15519 | |
| STVGVEDGAFREAIS | 146 | O43155 | |
| SRGSGAEVTLIDFGE | 561 | Q07912 | |
| ARVATGSRLEGLFSA | 121 | Q8N7S6 | |
| VVSEDESLLAAGFGR | 1091 | Q149M9 | |
| GATALAEAFRVIGTL | 196 | P46060 | |
| RIGVSFIDDGSNATD | 316 | Q8IUH3 | |
| EIASEALSRGFGSSA | 746 | Q6P2E9 | |
| DIVFLIDGSGSISSR | 151 | P20702 | |
| QFDGGVVLGADSRTT | 41 | P28072 | |
| ITFIESEEGSGRGAA | 436 | P35557 | |
| SVNGFISTLGLVDDR | 21 | Q14573 | |
| EFVFSEGSEASGRRV | 486 | Q9UFC0 | |
| GVTREDAGEVTFSLG | 486 | O75147 | |
| GTVITLISVFDRDFG | 366 | Q9UN72 | |
| TVRASDGRFAGLTSV | 1951 | Q14517 | |
| ALSGDGAGETFRLET | 181 | Q96JQ0 | |
| GTSVGRVFATDRDSG | 1121 | Q96JQ0 | |
| TGAITVRSAEGLDFE | 2121 | Q96JQ0 | |
| LVTASTDGIGFAIAR | 36 | Q6PKH6 | |
| TFTDIGLTARDNEGA | 226 | Q6ZVH7 | |
| VLSRFEFEGVSSTGE | 671 | Q14643 | |
| DSAAGLTVFLSEGRI | 691 | Q5IJ48 | |
| LARILSFSDSDFGGE | 391 | Q96S65 | |
| TEATFRGLVEDSGSF | 81 | Q8N158 | |
| FEVESELGRGATSIV | 46 | Q16566 | |
| EIASFGEGSRELFVR | 1356 | Q9BQS8 | |
| TGESFRTVLVNADGE | 556 | Q03252 | |
| GSRLVGIISSRDIDF | 151 | P12268 | |
| GRRSSAGSLESNVEF | 936 | Q6DN90 | |
| VFSSNRGELETLGTT | 4076 | Q2LD37 | |
| LFSISGVLQAGRRED | 806 | Q6VAB6 | |
| RTVAFSSDGLALVSG | 3751 | Q15751 | |
| AALDGTEREVLFTTG | 1096 | O75197 | |
| FRTGSDETTTLIGLL | 361 | Q9H252 | |
| VFDGTVIRELEGSLS | 531 | Q8N1V2 | |
| RSADFVVESIGSEVG | 566 | O75369 | |
| DDTLRSFDTVIGAGT | 356 | Q9H6A9 | |
| GAGTDFTLKISRVEA | 91 | A0A075B6R9 | |
| GGRDSTESEFRTATI | 6396 | Q7Z5P9 | |
| GERVATVLATDADSG | 551 | O60245 | |
| LSGSTEVISNEGGRF | 211 | Q9H792 | |
| GRSEIAFVATGTNLS | 51 | Q13951 | |
| ASFITGQSVDVDGGR | 251 | Q9BY49 | |
| LSFLDGARISIEGTV | 96 | Q96JB1 | |
| TEFTVDARSLTATGG | 1271 | Q14315 | |
| IRGDTLRGFDSTDLS | 1906 | Q5H8C1 | |
| LQESLGEGIRVATFS | 106 | Q969I3 | |
| EGRGTISQEDFERLS | 481 | Q8TDF6 | |
| GDGTIDFREFIIALS | 76 | P37235 | |
| ARGGDSITAVEARAF | 506 | O60462 | |
| AALDGTEREVLFFSG | 1086 | O75581 | |
| GVEIRDLSSSFRDGL | 21 | Q8N3F8 | |
| DFRTLSGVVEATAAA | 581 | P98088 | |
| LGEGSFSTVVLAREL | 61 | Q6A1A2 | |
| GGDVREATRDLLSFI | 56 | A6NEQ2 | |
| TRARTQLISDGGIFD | 401 | P18054 | |
| TLSGGFFVAVIERVE | 146 | Q3KNT7 | |
| RIEEDTGEIFTTGAR | 76 | Q9BZA7 | |
| TGEIFTTGARIDREK | 81 | Q9BZA7 | |
| VDSTRAIERLEGSSG | 421 | Q9Y5B6 | |
| LDGTGALGRFDFEIT | 706 | Q9BZ72 | |
| LVDELGRGTATFDGT | 1211 | P52701 | |
| GSEFSSLVEVRGTCV | 221 | Q15375 | |
| QGGARVVVDSDSLAF | 101 | Q86U28 | |
| DFIERTETAGELSRG | 6 | Q8NDY4 | |
| TGSELGRITFVFETL | 506 | A8MWY0 | |
| EDIVTQRGSRVLGSF | 3261 | Q9UPN3 | |
| LTITSTDNGRIFLAG | 216 | O75694 | |
| ITGLSTIDFRAGFSR | 311 | Q96RW7 | |
| RTFAEAAGSGETLSV | 216 | P51178 | |
| EIRERLGSGAFSEVV | 16 | Q6P2M8 | |
| DFRDVLGTGAFSEVI | 21 | Q14012 | |
| AESGGSTLKSIERFL | 111 | Q92794 | |
| VTDGSVTASGFRLRF | 2431 | O60494 | |
| AIRSGSEEVFRSGAL | 796 | Q9Y4D1 | |
| GRSSDLRAGEFVVAL | 266 | P83105 | |
| TRGSETDGRDQTIAL | 1291 | Q8N6C5 | |
| SGGLFSLTVQRAEVS | 761 | O75054 | |
| SNILSELRSFGRTAD | 116 | Q9NWB7 | |
| ILERGFDSVRSLSEG | 1221 | Q9P2K1 | |
| ERGVEFSLIGESTIR | 561 | P20023 | |
| IADVALSGGSRFQES | 1536 | Q5JSL3 | |
| ETFSFVLTGEDGSRR | 631 | Q9ULE3 | |
| ESGESQRGTDFSVLL | 131 | Q9NQS1 | |
| TKERVGEEALFTSGR | 241 | Q0VF96 | |
| GRDAVVRTDFGLTVT | 966 | Q9Y6R7 | |
| VLSVGANLTTFDGAR | 5236 | Q9Y6R7 | |
| RAEFTVETRSAGQGE | 301 | P21333 | |
| TEFSVDARALTQTGG | 1276 | P21333 | |
| TAFDVGSEKTRIGLA | 186 | Q05707 | |
| AVESDVRGITGVDLF | 176 | P53621 | |
| FRESELSKGGSVDIT | 2676 | Q8N3K9 | |
| EQSEAALISTRGTRF | 3886 | Q8N3K9 | |
| LFGESLRSGAEDATF | 741 | Q8NEA6 | |
| DESGTRAAAATGTIF | 356 | P05154 | |
| SIRDGSGLGRFSIDD | 1081 | Q8TDW7 | |
| SGLGRFSIDDESGVI | 1086 | Q8TDW7 | |
| FAIGVGSETEDAELR | 166 | Q96P44 | |
| IRDEFLRISTASGDG | 341 | P63092 | |
| LSSGINGSFLVRESE | 141 | P00519 | |
| DFGSGETARRIQDLI | 456 | Q96D53 | |
| IITREDGSRTFGFAL | 121 | Q6IQ26 | |
| VEFGILSRLLGDSTF | 311 | Q92611 | |
| RADGISSTFSQRIEG | 406 | P13612 | |
| VATEGVFVTELDGTR | 516 | Q8NEP3 | |
| TLGGETRILAVTDFE | 186 | Q6P179 | |
| SVALGSSGEVDRLVA | 31 | Q92837 | |
| AVLFGGETLTRARDT | 271 | Q8NEP7 | |
| GAGTDFTLKISRVEA | 91 | A0A0C4DH68 | |
| TFRVRAVTSEGAGEA | 716 | Q86VF2 | |
| RLLDGGDFVSLSSRE | 36 | Q5T9C2 | |
| EFAGSGNTTRRCLLE | 106 | Q5T8I3 | |
| EITESLVLGFGRTNS | 981 | Q5TBA9 | |
| SDVVVGLESFIGSER | 321 | Q96EB1 | |
| NATLDGTDVLFTGRE | 121 | O95865 | |
| RSFLLDILGATGSDS | 426 | O15523 | |
| ETDVFVVGTERGRAF | 51 | P78347 | |
| ALEEGRVREVFGSGT | 326 | O15382 | |
| GSSDRASFVIGIDLR | 4391 | Q9P225 | |
| RGTGALIFVIDSQDD | 136 | Q9NQL2 | |
| REGGVFVALTASVLS | 111 | Q9H228 | |
| GFDLDRVRTVTVTLG | 1456 | Q92736 | |
| GDGTIDFREFIIALS | 76 | P61601 | |
| TGGFVARDFTVLVDR | 776 | O43933 | |
| EEAGDSGFVSLSRLG | 56 | Q5VV67 | |
| RETTSLREEGGVSGF | 901 | Q86YS7 | |
| ADVVFLVDSSDRLGS | 26 | A6NMZ7 | |
| GTSREIGIQFFDSLL | 196 | P15509 | |
| LETRRVGTEGLVDSF | 276 | O75170 | |
| INEFLRELSFGRGST | 381 | Q15084 | |
| EDTGEIFTTGARIDR | 111 | Q9BZA8 | |
| LAFTRAGDGVRSEQI | 1166 | O60469 | |
| EVRFTSLGLGSALTT | 1381 | Q86VV8 | |
| DSSLIAGGFADSTVR | 481 | Q15542 | |
| SLRFSRDGEILASGS | 716 | Q15542 | |
| ATFRQDGRLLVAGSE | 86 | Q8TED0 | |
| TEDKEGGLFTVTLFR | 216 | Q8NEY4 | |
| FLQELVSVGLGDSRT | 356 | P05423 | |
| GRVGVFLDFESGSVS | 401 | Q96BQ3 | |
| GEATEGRISAIESLF | 631 | Q9Y6M7 | |
| GRISAIESLFGASLT | 636 | Q9Y6M7 | |
| VAEEDLRTLFANTGG | 466 | Q9UKA9 | |
| LDESRFENLGVSSLG | 81 | Q9Y3Z3 | |
| INVTGVGFDREASIR | 366 | Q6T4R5 | |
| ELGALRTSGLLFSVS | 521 | O95255 | |
| GITVQFAGRGSSEEA | 406 | Q86WR7 | |
| RRGTGVLVEFSELAF | 1021 | O94761 | |
| ETISSTATLGFRIEG | 801 | P27987 | |
| TRDFIEGGADDSITR | 21 | Q9NYQ3 | |
| SFKGRGRDIGSETEF | 556 | Q15858 | |
| GEGFLLVFSVTDRGS | 86 | P62070 | |
| GDSAIDRIFTLGNSE | 401 | Q86TU7 | |
| DGSFLVRDSESVAGA | 41 | O15357 | |
| FRLDDSLGGTSEVIQ | 526 | O75182 | |
| ERLALVTGGEIASTF | 321 | P78371 | |
| LLRFSDSEIGGITIA | 616 | P51692 | |
| RSLGGDVASDGDFLI | 346 | O00267 | |
| GEATEGRISAIESLF | 501 | Q2Y0W8 | |
| RFEISSSLVGLIDGS | 11 | G3V0H7 | |
| AGGTSLEVARFLSRE | 341 | Q9H6T0 | |
| DFGDSSGTLISRALV | 261 | P40967 | |
| AFLARGSGSTVSEAE | 301 | Q9UPV7 | |
| SIRFTAEEGDLGFTL | 516 | Q8IUC4 | |
| GSLARIFTSIQETGD | 196 | O75352 | |
| VGLTSTNAEVRGFID | 6 | Q14188 | |
| TFTVEDAVETIGFGR | 31 | Q8N434 | |
| GETFQASSRSVLIDG | 286 | O15198 | |
| LLRFSDSEIGGITIA | 616 | P42229 | |
| VSSLTSGLLTIGDRF | 921 | P53396 | |
| TVLESIRTAGTLFGE | 221 | Q5T9A4 | |
| DEGESLRGQTTSAFL | 86 | Q8NHS1 | |
| GEFSRALALEVGSSQ | 606 | Q86X52 | |
| FSCGVISTLRSREEG | 686 | Q86XI2 | |
| SLEGGTLRAAEGTSF | 56 | Q9NRU3 | |
| FSELRSVEGLQEGSV | 101 | O75153 | |
| GLTFSNELISRDEGL | 216 | Q7LG56 | |
| LAQTFATGEVSGRTL | 61 | P11086 | |
| VARGTEAVVFSIDGS | 1016 | O00562 | |
| RTEIFRSGNGTDETL | 86 | Q9H2S6 | |
| TVFGQELRVGSREAA | 91 | P56706 | |
| ELLEARFTGVASGST | 61 | Q9UKI8 | |
| SQRFEGTTSLGEVRT | 311 | Q4G0F5 | |
| RRLSIGLDNGTISEF | 81 | Q96P53 | |
| ADRISLAGSNIFTIG | 566 | Q7Z392 | |
| RDSSFLISGGFDRTV | 331 | Q6ZMY6 | |
| TVAELRRFFIGGSLE | 441 | Q9NXB0 | |
| GFLRDARQAEGVLSS | 1176 | O15020 | |
| SGDFARSLATRLVGS | 36 | Q658P3 | |
| ATEFDRLFEGTGARL | 61 | Q6NXR4 | |
| ADGIRDLLGTTQFLS | 831 | Q15413 | |
| TSIREDLVGGESFIT | 11 | Q8N801 | |
| DGTFLLRFSDSEIGG | 556 | P42226 | |
| TGLLDSLSGFRVDFT | 276 | Q9BSJ1 | |
| ASGRSAEVTLEVAGL | 391 | O15533 | |
| GALVALTSERFGEAS | 286 | Q6NSZ9 | |
| GSLSFEDVAVGFTRE | 21 | Q9BSK1 | |
| TLEGDIRLADFGVSA | 166 | O94804 | |
| NEISRLSRGSFEGLE | 141 | Q7L0X0 | |
| LSVAGTVELGFRSSA | 1441 | Q6ZS81 | |
| TVELGFRSSAITNTG | 1446 | Q6ZS81 | |
| SGDVITEGRIRVIFS | 876 | Q8IZH2 | |
| TSLRERGSDASGQLF | 1226 | P19174 | |
| VANGGASLTLVFERS | 906 | Q9P273 | |
| EAGTTRTFSVVAGDL | 1726 | O95359 | |
| GTLFEARAEVGILTR | 2376 | Q86WI1 | |
| DVLVGADSARAAITF | 136 | A8MWL6 | |
| SRGLSFDVSLEVSQG | 116 | P01833 | |
| FGQGRDRSSLLDDTT | 366 | Q8TEA7 | |
| GRTAAFRALSQGVES | 171 | O43615 | |
| TEGFDVRSVGNTLVL | 231 | Q86WT1 | |
| GAVIGGRVSFASTDE | 501 | Q9UIA9 | |
| LTGRFSRAGATLSAE | 81 | Q9ULT6 | |
| GRVGVFLDFESGSVS | 401 | A6NCK2 | |
| SSNSLTFGDGVLERR | 336 | Q8TF42 | |
| QRLEGDVVSGTESLF | 146 | P52746 | |
| LETGTQLFSGRSDFR | 321 | Q64LD2 | |
| FSDEVTAGLRISDGV | 211 | Q15029 | |
| ELFGRVTSRVTNDGE | 696 | Q6P3X3 | |
| AGSLIFRAISSIGLE | 36 | Q9HD89 | |
| TLSSSRQRGGESDFL | 6 | Q9Y6X0 | |
| EGDTVRDSIGFISSQ | 1711 | Q14966 | |
| FSLGGETRSENRELA | 256 | Q15776 | |
| ETRLDALDSFGSTRG | 356 | Q9UGR2 | |
| QELLRTTGASDTFEG | 106 | P24723 | |
| RAGEITSDGLSFLFL | 346 | Q5T7N2 | |
| FEESDLVGARGTFGS | 766 | Q9ULH4 | |
| GDLSVRDAAVDTLFG | 266 | Q9UHQ1 | |
| AIFTELGRIGALSAT | 1211 | Q5VTT5 | |
| GTGDLDLLSAFRRTS | 261 | Q14896 |